Background  	Background  	 NNP	B-NP
Sequence  	Sequence  	 NNP	I-NP
homology  	homology  	 NN	I-NP
between  	between  	 IN	O
the  	the  	 DT	O
serotonin  	serotonin  	 JJ	B-NP
type  	type  	 NN	I-NP
3  	3  	 CD	O
receptor  	receptor  	 NN	B-NP
( 	( 	 -LRB-	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R 	R 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
nicotinic  	nicotinic  	 JJ	B-NP
acetylcholine  	acetylcholine  	 JJ	I-NP
receptor  	receptor  	 NN	I-NP
( 	( 	 -LRB-	O
nAChR 	nAChR 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
GABA  	GABA  	 NNP	B-NP
A  	A  	 DT	O
receptor  	receptor  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
glycine  	glycine  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
suggests  	suggests  	 VBZ	O
a  	a  	 DT	O
large  	large  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
structural  	structural  	 JJ	B-NP
similarity  	similarity  	 NN	I-NP
within  	within  	 IN	O
this  	this  	 DT	O
superfamily  	superfamily  	 NN	O
of  	of  	 IN	O
ligand  	ligand  	 FW	B-NP
gated  	gated  	 FW	I-NP
ion  	ion  	 FW	I-NP
channels  	channels  	 FW	I-NP
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
3  	3  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
presumed  	presumed  	 JJ	O
structural  	structural  	 JJ	B-NP
homology  	homology  	 NN	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
to  	to  	 TO	O
guide  	guide  	 VB	O
site  	site  	 NN	O
directed  	directed  	 VBD	O
mutagenesis  	mutagenesis  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	O
particular  	particular  	 JJ	O
receptor  	receptor  	 NN	B-NP
subtypes 	subtypes 	 NN	I-NP
.  	.  	 .	O
On  	On  	 IN	O
a  	a  	 DT	O
gross  	gross  	 JJ	O
level 	level 	 NN	O
,  	,  	 ,	O
all  	all  	 DT	O
members  	members  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
superfamily  	superfamily  	 JJ	O
assemble  	assemble  	 NN	O
as  	as  	 IN	O
pentameric  	pentameric  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
some  	some  	 DT	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
receptors  	receptors  	 NNS	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
assembled  	assembled  	 VBN	O
from  	from  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
subunit  	subunit  	 NNS	B-NP
( 	( 	 -LRB-	O
5-HT  	5-HT  	 NNP	O
3A  	3A  	 NNP	O
R  	R  	 NNP	O
and  	and  	 CC	O
nicotinic  	nicotinic  	 CD	O
α7  	α7  	 CD	O
receptors 	receptors 	 CD	O
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
1  	1  	 CD	O
5  	5  	 CD	O
6  	6  	 CD	O
7  	7  	 CD	O
8  	8  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
other  	other  	 JJ	O
cases 	cases 	 NNS	O
,  	,  	 ,	O
at  	at  	 IN	O
least  	least  	 JJS	O
two  	two  	 CD	O
different  	different  	 JJ	O
subunits  	subunits  	 NNS	B-NP
are  	are  	 VBP	O
required  	required  	 VBN	O
[  	[  	 -LRB-	O
2  	2  	 CD	O
4  	4  	 CD	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
ligand  	ligand  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
site  	site  	 NN	I-NP
is  	is  	 VBZ	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
formed  	formed  	 VBN	O
at  	at  	 IN	O
the  	the  	 DT	O
junction  	junction  	 NN	O
between  	between  	 IN	O
two  	two  	 CD	O
subunits  	subunits  	 NNS	B-NP
[  	[  	 -LRB-	O
2  	2  	 CD	O
4  	4  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Based  	Based  	 VBN	O
on  	on  	 IN	O
data  	data  	 NNS	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
affinity  	affinity  	 JJ	B-NP
labeling  	labeling  	 NN	I-NP
and  	and  	 CC	O
site  	site  	 NN	O
directed  	directed  	 VBD	O
mutagenesis  	mutagenesis  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
several  	several  	 JJ	O
regions  	regions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
nicotinic  	nicotinic  	 JJ	B-NP
acetylcholine  	acetylcholine  	 JJ	I-NP
receptor  	receptor  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
implicated  	implicated  	 VBN	O
in  	in  	 IN	O
ligand  	ligand  	 JJ	O
binding  	binding  	 NNS	O
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Six  	Six  	 CD	O
essential  	essential  	 JJ	B-NP
loops  	loops  	 NNS	I-NP
appear  	appear  	 VBP	O
to  	to  	 TO	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
position  	position  	 NN	O
of  	of  	 IN	O
each  	each  	 DT	O
loop  	loop  	 NN	O
differing  	differing  	 VBG	O
slightly  	slightly  	 RB	O
depending  	depending  	 VBG	O
on  	on  	 RP	O
whether  	whether  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
is  	is  	 VBZ	O
heteromeric  	heteromeric  	 VBN	O
or  	or  	 CC	O
homomeric  	homomeric  	 NNS	B-NP
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
homomeric  	homomeric  	 JJ	B-NP
receptors  	receptors  	 JJ	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
α7  	α7  	 NNP	O
nAChR 	nAChR 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
loops  	loops  	 NNS	O
are  	are  	 VBP	O
identified  	identified  	 VBN	O
as  	as  	 IN	O
A 	A 	 NNP	O
,  	,  	 ,	O
B 	B 	 NNP	O
,  	,  	 ,	O
C 	C 	 NNP	O
,  	,  	 ,	O
D 	D 	 NNP	O
,  	,  	 ,	O
E  	E  	 NNP	O
and  	and  	 CC	O
F  	F  	 NNP	O
[  	[  	 -LRB-	O
4  	4  	 CD	O
11  	11  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
that  	that  	 IN	O
interact  	interact  	 NN	O
with  	with  	 IN	O
ligands  	ligands  	 VBG	O
presumably  	presumably  	 RB	O
extend  	extend  	 VB	O
into  	into  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
from  	from  	 IN	O
these  	these  	 DT	O
loops 	loops 	 NNS	O
.  	.  	 .	O
Subunits  	Subunits  	 NNS	B-NP
are  	are  	 VBP	O
composed  	composed  	 VBN	O
of  	of  	 IN	O
2  	2  	 CD	O
faces  	faces  	 NNS	O
( 	( 	 -LRB-	O
+  	+  	 NNP	O
and  	and  	 CC	O
- 	- 	 NNP	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
the  	the  	 DT	O
+  	+  	 JJ	O
face  	face  	 NN	O
of  	of  	 IN	O
one  	one  	 CD	O
subunit  	subunit  	 CD	B-NP
forming  	forming  	 CD	O
one  	one  	 CD	O
side  	side  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
-  	-  	 :	O
face  	face  	 NN	O
of  	of  	 IN	O
another  	another  	 DT	O
subunit  	subunit  	 NN	B-NP
forming  	forming  	 VBG	O
the  	the  	 DT	O
complimentary  	complimentary  	 JJ	B-NP
side 	side 	 NN	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
binding  	binding  	 JJ	O
loops  	loops  	 NNS	O
( 	( 	 -LRB-	O
A 	A 	 NNP	O
,  	,  	 ,	O
B  	B  	 NNP	O
and  	and  	 CC	O
C 	C 	 NNP	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
present  	present  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
-  	-  	 :	O
face  	face  	 NN	O
while  	while  	 IN	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
loops  	loops  	 NNS	O
( 	( 	 -LRB-	O
D  	D  	 NNP	O
and  	and  	 CC	O
E 	E 	 NNP	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
present  	present  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
+  	+  	 NNP	O
face.  	face.  	 NNP	O
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
individual  	individual  	 JJ	B-NP
amino  	amino  	 JJ	I-NP
acids  	acids  	 NNS	I-NP
that  	that  	 WDT	O
form  	form  	 VBP	O
binding  	binding  	 JJ	O
interactions  	interactions  	 NNS	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
present  	present  	 JJ	O
on  	on  	 IN	O
a  	a  	 DT	O
ligand  	ligand  	 NNS	B-NP
are  	are  	 VBP	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
differ  	differ  	 VB	O
for  	for  	 IN	O
each  	each  	 DT	O
receptor  	receptor  	 NN	B-NP
subtype 	subtype 	 NN	I-NP
,  	,  	 ,	O
reflecting  	reflecting  	 VBG	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
particular  	particular  	 JJ	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
overall  	overall  	 JJ	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
domain  	domain  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
similar  	similar  	 JJ	O
even  	even  	 RB	O
for  	for  	 IN	O
binding  	binding  	 JJ	O
sites  	sites  	 NNS	O
with  	with  	 IN	O
different  	different  	 JJ	O
ligand  	ligand  	 JJ	B-NP
specificities 	specificities 	 NN	I-NP
.  	.  	 .	O
Identification  	Identification  	 NN	B-NP
of  	of  	 IN	I-NP
ligand  	ligand  	 JJ	I-NP
specificity  	specificity  	 NN	I-NP
requires  	requires  	 VBZ	O
identification  	identification  	 VBN	B-NP
of  	of  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
location  	location  	 NN	O
or  	or  	 CC	O
structure  	structure  	 NN	O
of  	of  	 IN	O
individual  	individual  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
site  	site  	 NN	I-NP
loops  	loops  	 NNS	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 JJ	I-NP
present  	present  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
particular  	particular  	 JJ	O
receptor  	receptor  	 NN	B-NP
subtype 	subtype 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
purpose  	purpose  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
is  	is  	 VBZ	O
to  	to  	 TO	O
extend  	extend  	 VB	O
the  	the  	 DT	O
information  	information  	 NN	O
available  	available  	 JJ	O
from  	from  	 IN	O
other  	other  	 JJ	O
members  	members  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
receptor  	receptor  	 NN	B-NP
family  	family  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R.  	R.  	 NNP	B-NP
Sequence  	Sequence  	 NNP	I-NP
homology  	homology  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
presumed  	presumed  	 JJ	O
structural  	structural  	 JJ	B-NP
similarity  	similarity  	 NN	I-NP
to  	to  	 TO	O
other  	other  	 JJ	O
ligand  	ligand  	 FW	B-NP
gated  	gated  	 FW	I-NP
ion  	ion  	 FW	I-NP
channels  	channels  	 FW	I-NP
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
E  	E  	 NN	B-NP
loop  	loop  	 NN	I-NP
region  	region  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3A  	3A  	 CD	O
R  	R  	 NN	O
forms  	forms  	 NNS	O
part  	part  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
ligand  	ligand  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
domain  	domain  	 NN	I-NP
for  	for  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands 	ligands 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
region  	region  	 NN	O
extends  	extends  	 VBZ	O
from  	from  	 IN	O
Y140  	Y140  	 CD	B-NP
to  	to  	 TO	O
K153  	K153  	 CD	B-NP
and  	and  	 CC	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
homologous  	homologous  	 JJ	B-NP
sequences  	sequences  	 NN	I-NP
of  	of  	 IN	O
other  	other  	 JJ	O
representative  	representative  	 NN	B-NP
members  	members  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
family  	family  	 NN	O
are  	are  	 VBP	O
also  	also  	 RB	O
shown 	shown 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
center  	center  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
glycine  	glycine  	 JJ	I-NP
residue  	residue  	 NN	I-NP
that  	that  	 WDT	O
is  	is  	 VBZ	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
play  	play  	 VB	O
a  	a  	 DT	O
role  	role  	 NN	O
in  	in  	 IN	O
establishing  	establishing  	 VBG	O
a  	a  	 DT	O
hairpin  	hairpin  	 JJ	O
loop  	loop  	 NNS	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
x-ray  	x-ray  	 JJ	I-NP
crystallographic  	crystallographic  	 JJ	I-NP
data  	data  	 NNS	I-NP
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
an  	an  	 DT	O
ACh  	ACh  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
protein  	protein  	 NN	I-NP
( 	( 	 -LRB-	O
AChBP 	AChBP 	 NNP	B-NP
)  	)  	 -RRB-	O
shows  	shows  	 VBZ	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
a  	a  	 DT	O
3  	3  	 CD	O
residue  	residue  	 NNS	O
turn  	turn  	 VBP	O
containing  	containing  	 VBG	O
a  	a  	 DT	O
glycine  	glycine  	 JJ	B-NP
homologous  	homologous  	 NN	I-NP
to  	to  	 TO	O
G147  	G147  	 CD	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R.  	R.  	 NNP	O
On  	On  	 IN	O
either  	either  	 DT	O
side  	side  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
putative  	putative  	 JJ	B-NP
turn  	turn  	 NN	I-NP
region  	region  	 NN	I-NP
are  	are  	 VBP	O
residues  	residues  	 NNS	O
that  	that  	 WDT	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
as  	as  	 IN	O
important  	important  	 JJ	O
to  	to  	 TO	O
receptor  	receptor  	 VB	O
binding  	binding  	 JJ	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
formation  	formation  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
brings  	brings  	 VBZ	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
on  	on  	 IN	O
either  	either  	 DT	O
side  	side  	 NN	O
of  	of  	 IN	O
glycine  	glycine  	 NN	B-NP
into  	into  	 IN	O
close  	close  	 JJ	O
proximity  	proximity  	 NN	O
and  	and  	 CC	O
may  	may  	 MD	O
form  	form  	 VB	O
a  	a  	 DT	O
binding  	binding  	 JJ	O
pocket  	pocket  	 NN	O
that  	that  	 WDT	O
will  	will  	 MD	O
accommodate  	accommodate  	 VB	O
one  	one  	 CD	O
or  	or  	 CC	O
more  	more  	 RBR	O
functional  	functional  	 JJ	B-NP
groups 	groups 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
identify  	identify  	 VB	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
binding  	binding  	 JJ	O
loop  	loop  	 NN	O
with  	with  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands 	ligands 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
constructed  	constructed  	 VBN	O
alanine  	alanine  	 JJ	B-NP
mutations  	mutations  	 NNS	I-NP
of  	of  	 IN	O
residues  	residues  	 NNS	O
throughout  	throughout  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
and  	and  	 CC	O
evaluated  	evaluated  	 VBD	O
the  	the  	 DT	O
alteration  	alteration  	 NN	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	O
5  	5  	 CD	O
different  	different  	 JJ	O
classes  	classes  	 NNS	O
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands  	ligands  	 NNS	I-NP
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NN	O
identifies  	identifies  	 VBZ	O
3  	3  	 CD	O
tyrosine  	tyrosine  	 CD	B-NP
residues  	residues  	 NNS	I-NP
that  	that  	 WDT	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
interact  	interact  	 VB	O
selectively  	selectively  	 RB	O
with  	with  	 IN	O
each  	each  	 DT	O
structural  	structural  	 JJ	B-NP
class  	class  	 NN	I-NP
and  	and  	 CC	O
supports  	supports  	 VBZ	O
the  	the  	 DT	O
existence  	existence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor 	receptor 	 NN	B-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
All  	All  	 DT	O
mutant  	mutant  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
were  	were  	 VBD	O
tested  	tested  	 VBN	O
for  	for  	 IN	O
their  	their  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
bind  	bind  	 VB	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
antagonist  	antagonist  	 NNS	I-NP
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
.  	.  	 .	O
Table  	Table  	 NN	O
2shows  	2shows  	 VBZ	O
the  	the  	 DT	O
K  	K  	 NNP	O
d  	d  	 NN	O
values  	values  	 NNS	O
for  	for  	 IN	O
wildtype  	wildtype  	 JJ	O
mouse  	mouse  	 NN	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
Rs  	Rs  	 NNP	O
and  	and  	 CC	O
the  	the  	 DT	O
13  	13  	 CD	O
alanine  	alanine  	 NNS	B-NP
mutations  	mutations  	 VBP	I-NP
we  	we  	 PRP	O
evaluated.  	evaluated.  	 VBP	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
antagonist  	antagonist  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
wt  	wt  	 JJ	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
( 	( 	 -LRB-	O
K  	K  	 NNP	O
d  	d  	 SYM	O
=  	=  	 SYM	O
0.98  	0.98  	 FW	O
±  	±  	 FW	O
0.12  	0.12  	 FW	O
nM 	nM 	 FW	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
value  	value  	 NN	O
agrees  	agrees  	 VBZ	O
with  	with  	 IN	O
published  	published  	 JJ	O
data  	data  	 NNS	O
for  	for  	 IN	O
this  	this  	 DT	O
compound  	compound  	 NN	B-NP
[  	[  	 -LRB-	O
19  	19  	 CD	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
B  	B  	 SYM	B-NP
max  	max  	 JJ	I-NP
values  	values  	 NNS	I-NP
range  	range  	 VBP	O
from  	from  	 IN	O
the  	the  	 DT	O
5.5  	5.5  	 CD	O
pmoles 	pmoles 	 CD	B-NP
/ 	/ 	 CD	I-NP
mg  	mg  	 JJ	I-NP
protein  	protein  	 NN	I-NP
observed  	observed  	 VBD	O
for  	for  	 IN	O
E148A  	E148A  	 CD	O
to  	to  	 TO	O
0.30  	0.30  	 CD	O
pmoles 	pmoles 	 CD	B-NP
/ 	/ 	 CD	I-NP
mg  	mg  	 JJ	I-NP
protein  	protein  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
K153A  	K153A  	 JJ	O
mutation 	mutation 	 NN	O
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
some  	some  	 DT	O
variability  	variability  	 NN	O
in  	in  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
different  	different  	 JJ	O
receptors 	receptors 	 NNS	B-NP
.  	.  	 .	O
In  	In  	 IN	O
general 	general 	 JJ	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
receptor  	receptor  	 JJ	B-NP
expression  	expression  	 NN	I-NP
was  	was  	 VBD	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
that  	that  	 WDT	O
reported  	reported  	 VBD	O
by  	by  	 IN	O
other  	other  	 JJ	O
laboratories  	laboratories  	 NNS	O
[  	[  	 -LRB-	O
1  	1  	 CD	O
20  	20  	 CD	O
21  	21  	 CD	O
22  	22  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
detectable  	detectable  	 JJ	O
binding  	binding  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
G147A  	G147A  	 NNP	O
and  	and  	 CC	O
V149A  	V149A  	 CD	O
mutant  	mutant  	 CD	O
receptors 	receptors 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
all  	all  	 DT	O
other  	other  	 JJ	O
mutants 	mutants 	 NN	B-NP
,  	,  	 ,	O
decreases  	decreases  	 NNS	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NNS	B-NP
( 	( 	 -LRB-	O
increased  	increased  	 VBN	B-NP
K  	K  	 NN	I-NP
d  	d  	 LS	I-NP
)  	)  	 -RRB-	O
were  	were  	 VBD	O
observed  	observed  	 VBN	O
although  	although  	 IN	O
the  	the  	 DT	O
magnitude  	magnitude  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
change  	change  	 NN	O
was  	was  	 VBD	O
less  	less  	 JJR	O
than  	than  	 IN	O
10  	10  	 CD	O
fold  	fold  	 NN	O
in  	in  	 IN	O
all  	all  	 DT	O
cases 	cases 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
bar  	bar  	 NN	O
graph  	graph  	 NN	O
showing  	showing  	 VBG	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	B-NP
d  	d  	 JJ	I-NP
value  	value  	 NN	I-NP
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
each  	each  	 DT	O
alanine  	alanine  	 JJ	B-NP
mutation  	mutation  	 NN	I-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
2A 	2A 	 NNP	O
.  	.  	 .	O
The  	The  	 DT	O
largest  	largest  	 JJS	O
decreases  	decreases  	 NNS	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
Y142A  	Y142A  	 NNP	O
( 	( 	 -LRB-	O
4.6  	4.6  	 CD	O
fold 	fold 	 NN	O
,  	,  	 ,	O
Figure  	Figure  	 NNP	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
E148A  	E148A  	 NNP	O
( 	( 	 -LRB-	O
5.3  	5.3  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Q150A  	Q150A  	 NNP	O
-  	-  	 :	O
K153A  	K153A  	 CD	O
( 	( 	 -LRB-	O
6  	6  	 CD	O
-  	-  	 :	O
8  	8  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Inhibition  	Inhibition  	 JJ	O
binding  	binding  	 JJ	O
assays  	assays  	 NN	O
were  	were  	 VBD	O
also  	also  	 RB	O
conducted 	conducted 	 VBN	O
.  	.  	 .	O
Four  	Four  	 CD	O
test  	test  	 NN	B-NP
compounds  	compounds  	 NN	I-NP
with  	with  	 IN	O
structures  	structures  	 JJ	B-NP
representative  	representative  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
major  	major  	 JJ	O
classes  	classes  	 NNS	O
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands  	ligands  	 NNS	I-NP
were  	were  	 VBD	O
chosen 	chosen 	 VBN	O
:  	:  	 :	O
serotonin  	serotonin  	 CD	B-NP
( 	( 	 -LRB-	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
endogenous  	endogenous  	 JJ	B-NP
agonist 	agonist 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
m  	m  	 JJ	O
-chlorophenylbiguanide  	-chlorophenylbiguanide  	 NN	O
(  	(  	 -LRB-	O
m  	m  	 UH	O
CPBG 	CPBG 	 UH	B-NP
,  	,  	 ,	O
agonist 	agonist 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
d  	d  	 JJ	O
-tubocurarine  	-tubocurarine  	 NN	O
(  	(  	 -LRB-	O
d  	d  	 LS	O
-tc 	-tc 	 JJ	O
,  	,  	 ,	O
antagonist 	antagonist 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
lerisetron  	lerisetron  	 NNS	B-NP
( 	( 	 -LRB-	O
antagonist 	antagonist 	 LS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
for  	for  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
by  	by  	 IN	O
all  	all  	 DT	O
four  	four  	 CD	O
compounds  	compounds  	 NNS	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
3 	3 	 CD	O
.  	.  	 .	O
Little  	Little  	 JJ	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
mutations 	mutations 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
values  	values  	 NNS	O
highlighted  	highlighted  	 VBD	O
in  	in  	 IN	O
bold  	bold  	 JJ	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
3represent  	3represent  	 CD	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 NNS	O
for  	for  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
on  	on  	 IN	O
mutant  	mutant  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
that  	that  	 WDT	O
increased  	increased  	 VBD	O
over  	over  	 IN	O
10  	10  	 CD	O
fold  	fold  	 NNS	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 VBD	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
wildtype  	wildtype  	 JJ	B-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
bar  	bar  	 NN	O
chart  	chart  	 NN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
2Billustrates  	2Billustrates  	 CD	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 VBZ	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
each  	each  	 DT	O
mutation  	mutation  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
test  	test  	 NN	B-NP
compounds 	compounds 	 NN	I-NP
.  	.  	 .	O
Ratios  	Ratios  	 NNS	O
of  	of  	 IN	O
K  	K  	 NNP	O
i  	i  	 NNS	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
as  	as  	 IN	O
positive  	positive  	 JJ	O
for  	for  	 IN	O
increases  	increases  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
on  	on  	 FW	O
mutant  	mutant  	 FW	B-NP
receptors  	receptors  	 FW	I-NP
versus  	versus  	 FW	O
wildtype  	wildtype  	 FW	B-NP
and  	and  	 CC	O
negative  	negative  	 JJ	O
for  	for  	 IN	O
decreases 	decreases 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
positive  	positive  	 JJ	B-NP
change  	change  	 NN	I-NP
thus  	thus  	 RB	O
corresponds  	corresponds  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
compound  	compound  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Large  	Large  	 JJ	B-NP
decreases  	decreases  	 NNS	I-NP
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
select  	select  	 JJ	O
compounds  	compounds  	 NNS	O
only  	only  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
Y140A 	Y140A 	 NNP	O
,  	,  	 ,	O
Y142A  	Y142A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
mutations 	mutations 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
more  	more  	 RBR	O
detailed  	detailed  	 JJ	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
competition  	competition  	 NN	O
binding  	binding  	 JJ	O
data  	data  	 NNS	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
Y140A 	Y140A 	 NNP	O
,  	,  	 ,	O
Y142A  	Y142A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
mutations  	mutations  	 NN	O
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
4 	4 	 CD	O
.  	.  	 .	O
For  	For  	 IN	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
110  	110  	 CD	O
fold  	fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
and  	and  	 CC	O
Y152A  	Y152A  	 NNP	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
24  	24  	 CD	O
fold  	fold  	 JJ	O
increase 	increase 	 NN	O
.  	.  	 .	O
No  	No  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation  	mutation  	 NN	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4A 	4A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
agonist  	agonist  	 NNS	O
m  	m  	 VBD	O
CPBG  	CPBG  	 NNP	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
profile  	profile  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
values  	values  	 VBZ	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
mutations  	mutations  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
tyrosines  	tyrosines  	 NNS	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4B 	4B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
As  	As  	 RB	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
large  	large  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
( 	( 	 -LRB-	O
160  	160  	 CD	O
fold 	fold 	 CD	O
)  	)  	 -RRB-	O
while  	while  	 IN	O
the  	the  	 DT	O
Y14  	Y14  	 NNP	O
0A  	0A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
mutations  	mutations  	 NNS	O
produced  	produced  	 VBD	O
only  	only  	 RB	O
7  	7  	 CD	O
and  	and  	 CC	O
24  	24  	 CD	O
fold  	fold  	 CD	O
changes  	changes  	 NNS	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
binding  	binding  	 NN	O
was  	was  	 VBD	O
altered  	altered  	 VBN	O
only  	only  	 RB	O
slightly  	slightly  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 NNP	O
or  	or  	 CC	O
Y152A  	Y152A  	 CD	O
mutations  	mutations  	 NNS	O
( 	( 	 -LRB-	O
6.5  	6.5  	 CD	O
fold  	fold  	 NNS	O
and  	and  	 CC	O
10  	10  	 CD	O
fold  	fold  	 CD	O
changes  	changes  	 NNS	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation 	mutation 	 NN	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
produced  	produced  	 VBD	O
a  	a  	 DT	O
50  	50  	 CD	O
fold  	fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 VBD	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors  	receptors  	 NNS	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4C 	4C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
value  	value  	 NN	O
for  	for  	 IN	O
lerisetron  	lerisetron  	 JJ	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
binding  	binding  	 NN	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
160  	160  	 CD	O
fold  	fold  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation  	mutation  	 NN	O
and  	and  	 CC	O
190  	190  	 CD	O
fold  	fold  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y152A  	Y152A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Only  	Only  	 RB	O
a  	a  	 DT	O
4.6  	4.6  	 CD	O
fold  	fold  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 VBD	O
resulted  	resulted  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Lerisetron  	Lerisetron  	 NNP	O
was  	was  	 VBD	O
the  	the  	 DT	O
only  	only  	 JJ	O
compound  	compound  	 NN	O
for  	for  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
large  	large  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
Y152A  	Y152A  	 JJ	O
mutation  	mutation  	 NN	O
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
4D 	4D 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
smaller  	smaller  	 JJR	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
5-HT  	5-HT  	 NNP	O
and  	and  	 CC	O
m  	m  	 JJ	O
CPBG  	CPBG  	 NNP	O
( 	( 	 -LRB-	O
24  	24  	 CD	O
fold  	fold  	 NN	O
for  	for  	 IN	O
both 	both 	 DT	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
only  	only  	 RB	O
a  	a  	 DT	O
10  	10  	 CD	O
fold  	fold  	 JJ	O
change  	change  	 NN	O
for  	for  	 IN	O
d  	d  	 JJ	O
-tc 	-tc 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
patch  	patch  	 NN	O
clamp  	clamp  	 NN	O
studies 	studies 	 NNS	O
,  	,  	 ,	O
5-HT  	5-HT  	 CD	O
perfusion  	perfusion  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
transfected  	transfected  	 VBN	O
with  	with  	 IN	O
Y140A  	Y140A  	 NNP	O
and  	and  	 CC	O
Y142A  	Y142A  	 NNP	O
cDNA  	cDNA  	 NNP	O
produced  	produced  	 VBD	O
no  	no  	 DT	O
responses  	responses  	 NNS	O
at  	at  	 IN	O
5-HT  	5-HT  	 CD	O
concentrations  	concentrations  	 NNS	O
of  	of  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
1  	1  	 CD	O
mM  	mM  	 NN	O
although  	although  	 IN	O
specific  	specific  	 JJ	O
binding  	binding  	 NN	O
to  	to  	 TO	O
these  	these  	 DT	O
receptors  	receptors  	 NN	B-NP
was  	was  	 VBD	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
receptor  	receptor  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
studies 	studies 	 NNS	I-NP
.  	.  	 .	O
Unlike  	Unlike  	 IN	O
Y140A  	Y140A  	 NNP	O
and  	and  	 CC	O
Y142A 	Y142A 	 NNP	O
,  	,  	 ,	O
Y152A  	Y152A  	 CD	O
receptors  	receptors  	 NNS	O
responded  	responded  	 VBD	O
to  	to  	 TO	O
application  	application  	 NN	O
of  	of  	 IN	O
5-HT 	5-HT 	 CD	O
.  	.  	 .	O
Due  	Due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
low  	low  	 JJ	O
potency  	potency  	 NN	O
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
on  	on  	 IN	O
these  	these  	 DT	O
receptors 	receptors 	 NN	B-NP
,  	,  	 ,	O
only  	only  	 RB	O
a  	a  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
response  	response  	 NN	I-NP
curve  	curve  	 NN	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
determined  	determined  	 VBN	O
( 	( 	 -LRB-	O
up  	up  	 RB	O
to  	to  	 TO	O
1  	1  	 CD	O
mM 	mM 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
value  	value  	 NN	O
was  	was  	 VBD	O
estimated  	estimated  	 VBN	O
as  	as  	 IN	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
370  	370  	 CD	O
μM  	μM  	 NNS	B-NP
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
5 	5 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
value  	value  	 NN	O
shows  	shows  	 VBZ	O
a  	a  	 DT	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
140  	140  	 CD	O
fold  	fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors 	receptors 	 NNS	B-NP
;  	;  	 :	O
a  	a  	 DT	O
larger  	larger  	 JJR	O
change  	change  	 NN	O
than  	than  	 IN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
( 	( 	 -LRB-	O
24  	24  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
dramatic  	dramatic  	 JJ	O
change  	change  	 NN	O
observed  	observed  	 VBD	O
for  	for  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
currents  	currents  	 NNS	O
was  	was  	 VBD	O
an  	an  	 DT	O
alteration  	alteration  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
kinetics  	kinetics  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
response  	response  	 NN	B-NP
elicited  	elicited  	 NN	I-NP
by  	by  	 IN	O
application  	application  	 NN	O
of  	of  	 IN	O
5-HT 	5-HT 	 CD	O
.  	.  	 .	O
Y152A  	Y152A  	 NNP	O
mutant  	mutant  	 JJ	O
receptors  	receptors  	 NNS	O
displayed  	displayed  	 VBD	O
much  	much  	 RB	O
slower  	slower  	 JJR	O
rise  	rise  	 NN	B-NP
times  	times  	 NNS	I-NP
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors  	receptors  	 VBN	O
at  	at  	 IN	O
all  	all  	 DT	O
concentrations  	concentrations  	 NNS	B-NP
tested 	tested 	 VBD	O
.  	.  	 .	O
Peak  	Peak  	 JJ	O
wt  	wt  	 JJ	B-NP
responses  	responses  	 NNS	I-NP
were  	were  	 VBD	O
typically  	typically  	 RB	O
obtained  	obtained  	 VBN	O
in  	in  	 IN	O
less  	less  	 JJR	O
than  	than  	 IN	O
80  	80  	 CD	O
ms  	ms  	 NN	B-NP
while  	while  	 IN	O
Y152A  	Y152A  	 CD	O
responses  	responses  	 NNS	O
required  	required  	 VBN	O
several  	several  	 JJ	O
seconds  	seconds  	 NNS	O
to  	to  	 TO	O
plateau 	plateau 	 NN	O
.  	.  	 .	O
Desensitization  	Desensitization  	 JJ	B-NP
kinetics  	kinetics  	 NN	I-NP
were  	were  	 VBD	O
also  	also  	 RB	O
altered 	altered 	 VBN	O
.  	.  	 .	O
While  	While  	 IN	O
wt  	wt  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
desensitized  	desensitized  	 VBP	O
rapidly 	rapidly 	 RB	O
,  	,  	 ,	O
mutant  	mutant  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
showed  	showed  	 VBD	O
no  	no  	 DT	O
desensitization  	desensitization  	 NN	B-NP
during  	during  	 IN	O
the  	the  	 DT	O
8  	8  	 CD	O
s  	s  	 CD	B-NP
perfusion  	perfusion  	 JJ	I-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
Discussion  	Discussion  	 NN	O
The  	The  	 DT	O
putative  	putative  	 JJ	O
E-loop  	E-loop  	 JJ	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
LGIC  	LGIC  	 NNP	O
family  	family  	 NN	O
of  	of  	 IN	O
receptors  	receptors  	 NN	O
is  	is  	 VBZ	O
homologous  	homologous  	 VBN	O
to  	to  	 TO	O
residues  	residues  	 CD	O
Y140  	Y140  	 CD	O
through  	through  	 IN	O
K153  	K153  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
[  	[  	 -LRB-	O
4  	4  	 CD	O
12  	12  	 CD	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Structure-function  	Structure-function  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
have  	have  	 VBP	O
been  	been  	 VBN	O
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
several  	several  	 JJ	O
other  	other  	 JJ	O
members  	members  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
family  	family  	 NN	O
of  	of  	 IN	O
receptors  	receptors  	 NNS	B-NP
including  	including  	 VBG	I-NP
GABA  	GABA  	 NNP	I-NP
A  	A  	 NNP	O
and  	and  	 CC	O
nAChR  	nAChR  	 JJ	B-NP
subtypes 	subtypes 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
each  	each  	 DT	O
case 	case 	 NN	O
,  	,  	 ,	O
residues  	residues  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
that  	that  	 IN	O
alter  	alter  	 NN	O
either  	either  	 CC	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
selective  	selective  	 JJ	B-NP
ligands  	ligands  	 NN	I-NP
or  	or  	 CC	O
receptor  	receptor  	 JJ	B-NP
function  	function  	 NN	I-NP
[  	[  	 -LRB-	O
4  	4  	 CD	O
11  	11  	 CD	O
12  	12  	 CD	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
this  	this  	 DT	O
loop  	loop  	 NN	O
also  	also  	 RB	O
contains  	contains  	 VBZ	O
residues  	residues  	 JJ	O
critical  	critical  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
structure  	structure  	 NN	O
or  	or  	 CC	O
function  	function  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R 	R 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
constructed  	constructed  	 VBN	O
alanine  	alanine  	 JJ	B-NP
mutations  	mutations  	 NNS	I-NP
of  	of  	 IN	I-NP
amino  	amino  	 JJ	I-NP
acids  	acids  	 NNS	I-NP
throughout  	throughout  	 IN	O
the  	the  	 DT	O
homologous  	homologous  	 JJ	B-NP
region  	region  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
mouse  	mouse  	 NN	O
5-HT  	5-HT  	 CD	O
3AS  	3AS  	 CD	O
R  	R  	 NN	O
and  	and  	 CC	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
affects  	affects  	 NN	O
on  	on  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
5  	5  	 CD	O
different  	different  	 JJ	O
structural  	structural  	 JJ	B-NP
classes  	classes  	 NNS	I-NP
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands 	ligands 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
have  	have  	 VBP	O
identified  	identified  	 VBN	O
three  	three  	 CD	O
tyrosine  	tyrosine  	 CD	B-NP
residues  	residues  	 NNS	I-NP
that  	that  	 WDT	O
appear  	appear  	 VBP	O
to  	to  	 TO	O
play  	play  	 VB	O
a  	a  	 DT	O
role  	role  	 NN	O
in  	in  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
selective  	selective  	 JJ	B-NP
ligands  	ligands  	 NN	I-NP
to  	to  	 TO	O
this  	this  	 DT	O
receptor 	receptor 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
our  	our  	 PRP$	O
data  	data  	 NNS	O
support  	support  	 VBP	O
the  	the  	 DT	O
existence  	existence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
as  	as  	 RB	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
hypothesized  	hypothesized  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
nAChR  	nAChR  	 JJ	O
and  	and  	 CC	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
homologous  	homologous  	 JJ	B-NP
AChBP  	AChBP  	 NN	I-NP
[  	[  	 -LRB-	O
12  	12  	 CD	O
23  	23  	 CD	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Representative  	Representative  	 JJ	B-NP
members  	members  	 NNS	I-NP
of  	of  	 IN	O
5  	5  	 CD	O
major  	major  	 JJ	O
structural  	structural  	 JJ	B-NP
classes  	classes  	 NNS	I-NP
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands  	ligands  	 NNS	I-NP
were  	were  	 VBD	O
tested  	tested  	 VBN	O
on  	on  	 IN	O
all  	all  	 DT	O
mutants  	mutants  	 NN	B-NP
( 	( 	 -LRB-	O
Figure  	Figure  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
ligands  	ligands  	 NNS	B-NP
include  	include  	 VBP	O
the  	the  	 DT	O
antagonists  	antagonists  	 NNS	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
,  	,  	 ,	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
and  	and  	 CC	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
agonists  	agonists  	 JJ	O
5-HT  	5-HT  	 NN	O
and  	and  	 CC	O
m  	m  	 JJ	B-NP
CPBG 	CPBG 	 NNP	I-NP
.  	.  	 .	O
Most  	Most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
mutations  	mutations  	 NN	O
tested  	tested  	 VBD	O
produced  	produced  	 VBN	O
only  	only  	 RB	O
minor  	minor  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
for  	for  	 IN	O
these  	these  	 DT	O
ligands 	ligands 	 NN	B-NP
.  	.  	 .	O
Large  	Large  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
binding  	binding  	 NNS	O
are  	are  	 VBP	O
only  	only  	 RB	O
apparent  	apparent  	 JJ	O
on  	on  	 IN	O
Y140A 	Y140A 	 NNP	O
,  	,  	 ,	O
Y142A  	Y142A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
receptors  	receptors  	 NNS	O
for  	for  	 IN	O
select  	select  	 JJ	O
ligands 	ligands 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
resulting  	resulting  	 VBG	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
individual  	individual  	 JJ	I-NP
mutations  	mutations  	 NNS	I-NP
are  	are  	 VBP	O
specific  	specific  	 JJ	O
to  	to  	 TO	O
particular  	particular  	 JJ	O
structural  	structural  	 JJ	B-NP
classes  	classes  	 NNS	I-NP
of  	of  	 IN	I-NP
ligands 	ligands 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation  	mutation  	 NN	O
altered  	altered  	 VBD	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
inhibition 	inhibition 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
did  	did  	 VBD	O
not  	not  	 RB	O
alter  	alter  	 VB	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 VBD	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
any  	any  	 DT	O
other  	other  	 JJ	O
compound  	compound  	 NN	B-NP
tested 	tested 	 VBD	O
,  	,  	 ,	O
while  	while  	 IN	O
Y142A  	Y142A  	 NNP	O
altered  	altered  	 VBD	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
m  	m  	 JJ	B-NP
CPBG 	CPBG 	 NNP	I-NP
,  	,  	 ,	O
5-HT  	5-HT  	 NNP	O
and  	and  	 CC	O
lerisetron  	lerisetron  	 NNS	B-NP
but  	but  	 CC	O
had  	had  	 VBD	O
little  	little  	 RB	O
if  	if  	 IN	O
any  	any  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
inhibition  	inhibition  	 NN	O
by  	by  	 IN	O
d  	d  	 JJ	O
-tc 	-tc 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
indicate  	indicate  	 VBP	O
the  	the  	 DT	O
highly  	highly  	 RB	O
specific  	specific  	 JJ	O
nature  	nature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
introduced  	introduced  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
alanine  	alanine  	 JJ	B-NP
mutations  	mutations  	 NNS	I-NP
and  	and  	 CC	O
appear  	appear  	 VB	O
to  	to  	 TO	O
reflect  	reflect  	 VB	O
specific  	specific  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
ligand 	ligand 	 FW	B-NP
/ 	/ 	 FW	I-NP
receptor  	receptor  	 FW	I-NP
interaction 	interaction 	 FW	I-NP
.  	.  	 .	O
Binding  	Binding  	 VBG	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
is  	is  	 VBZ	O
altered  	altered  	 VBN	O
only  	only  	 RB	O
slightly  	slightly  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
alanine  	alanine  	 JJ	B-NP
mutations  	mutations  	 NNS	I-NP
introduced  	introduced  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
(  	(  	 -LRB-	O
< 	< 	 SYM	O
10  	10  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
result  	result  	 NN	O
indicates  	indicates  	 VBZ	O
the  	the  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
involvement  	involvement  	 NN	O
of  	of  	 IN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
binding  	binding  	 JJ	O
loop  	loop  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
apparent 	apparent 	 JJ	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
that  	that  	 WDT	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
does  	does  	 VBZ	O
occupy  	occupy  	 VBG	O
the  	the  	 DT	O
same  	same  	 JJ	O
binding  	binding  	 JJ	O
cleft  	cleft  	 NN	O
as  	as  	 IN	O
other  	other  	 JJ	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
ligands  	ligands  	 VBZ	O
as  	as  	 RB	O
evidenced  	evidenced  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
5-HT 	5-HT 	 NNP	O
,  	,  	 ,	O
m  	m  	 VBG	O
CPBG 	CPBG 	 NNP	B-NP
,  	,  	 ,	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
and  	and  	 CC	O
lerisetron  	lerisetron  	 JJ	O
to  	to  	 TO	O
displace  	displace  	 VB	O
it  	it  	 PRP	O
from  	from  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
lack  	lack  	 NN	O
of  	of  	 IN	O
any  	any  	 DT	O
large  	large  	 JJ	O
change  	change  	 NN	O
in  	in  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
granisetron  	granisetron  	 NN	B-NP
supports  	supports  	 VBZ	O
our  	our  	 PRP$	O
contention  	contention  	 NN	O
that  	that  	 IN	O
there  	there  	 EX	O
is  	is  	 VBZ	O
little  	little  	 RB	O
global  	global  	 JJ	O
structural  	structural  	 JJ	B-NP
perturbation  	perturbation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
the  	the  	 DT	O
introduction  	introduction  	 NN	B-NP
of  	of  	 IN	O
each  	each  	 DT	O
individual  	individual  	 JJ	B-NP
alanine  	alanine  	 JJ	I-NP
mutation 	mutation 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
for  	for  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
by  	by  	 IN	O
5-HT  	5-HT  	 NNP	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
110  	110  	 CD	O
fold  	fold  	 NN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
similar  	similar  	 JJ	O
increase  	increase  	 NN	O
was  	was  	 VBD	O
also  	also  	 RB	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
m  	m  	 JJ	B-NP
CPBG  	CPBG  	 NNP	I-NP
( 	( 	 -LRB-	O
160  	160  	 CD	O
fold 	fold 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
Y140A  	Y140A  	 NNP	O
and  	and  	 CC	O
Y152A  	Y152A  	 CD	O
mutations  	mutations  	 NNS	O
produced  	produced  	 VBD	O
relatively  	relatively  	 RB	O
small  	small  	 JJ	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
.  	.  	 .	O
Since  	Since  	 IN	O
both  	both  	 DT	O
compounds  	compounds  	 NNS	O
are  	are  	 VBP	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
agonists 	agonists 	 NN	I-NP
,  	,  	 ,	O
they  	they  	 PRP	O
are  	are  	 VBP	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
share  	share  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
binding  	binding  	 JJ	O
interactions 	interactions 	 NNS	B-NP
.  	.  	 .	O
One  	One  	 CD	O
of  	of  	 IN	O
these  	these  	 DT	O
interactions  	interactions  	 NN	B-NP
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
with  	with  	 IN	O
Y142 	Y142 	 CD	B-NP
.  	.  	 .	O
Other  	Other  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
also  	also  	 RB	O
identified  	identified  	 VBN	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
interactions  	interactions  	 NNS	O
for  	for  	 IN	O
agonists 	agonists 	 NN	B-NP
.  	.  	 .	O
R91 	R91 	 NNP	B-NP
,  	,  	 ,	O
E106 	E106 	 NNP	B-NP
,  	,  	 ,	O
F107 	F107 	 NNP	B-NP
,  	,  	 ,	O
W183  	W183  	 NNP	B-NP
and  	and  	 CC	O
several  	several  	 JJ	O
residues  	residues  	 JJ	O
adjacent  	adjacent  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
M1  	M1  	 JJ	B-NP
region  	region  	 NN	I-NP
have  	have  	 VBP	O
all  	all  	 RB	O
been  	been  	 VBN	O
demonstrated  	demonstrated  	 VBN	O
to  	to  	 TO	O
alter  	alter  	 VB	O
the  	the  	 DT	O
action  	action  	 NN	O
of  	of  	 IN	O
5-HT  	5-HT  	 NNP	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
m  	m  	 JJ	B-NP
CPBG  	CPBG  	 NNP	I-NP
[  	[  	 -LRB-	O
20  	20  	 CD	O
21  	21  	 CD	O
25  	25  	 CD	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Within  	Within  	 IN	O
the  	the  	 DT	O
crystal  	crystal  	 NN	O
structure  	structure  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
AChBP 	AChBP 	 JJ	O
,  	,  	 ,	O
homologous  	homologous  	 JJ	B-NP
residues  	residues  	 NNS	I-NP
are  	are  	 VBP	O
located  	located  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
apparent  	apparent  	 JJ	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
agonist  	agonist  	 NN	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
are  	are  	 VBP	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
their  	their  	 PRP$	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
these  	these  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
residues 	residues 	 NNS	O
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
stable  	stable  	 JJ	O
receptor  	receptor  	 NN	B-NP
conformations 	conformations 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
the  	the  	 DT	O
channel  	channel  	 NN	O
open  	open  	 JJ	O
state 	state 	 NN	O
.  	.  	 .	O
Identification  	Identification  	 NN	B-NP
of  	of  	 IN	O
interacting  	interacting  	 JJ	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
location  	location  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
tertiary  	tertiary  	 JJ	B-NP
structure  	structure  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptor  	receptor  	 NN	I-NP
may  	may  	 MD	O
provide  	provide  	 VB	O
clues  	clues  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
channel  	channel  	 NN	O
opening 	opening 	 NN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
homologous  	homologous  	 VBP	O
to  	to  	 TO	O
Y142  	Y142  	 CD	B-NP
and  	and  	 CC	O
W183  	W183  	 NNP	B-NP
( 	( 	 -LRB-	O
R104  	R104  	 NNP	B-NP
and  	and  	 CC	O
W143  	W143  	 CD	B-NP
respectively 	respectively 	 CD	O
)  	)  	 -RRB-	O
are  	are  	 VBP	O
in  	in  	 IN	O
close  	close  	 JJ	O
proximity  	proximity  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
AChBP 	AChBP 	 JJ	O
,  	,  	 ,	O
although  	although  	 IN	O
on  	on  	 IN	O
complementary  	complementary  	 JJ	B-NP
faces  	faces  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptor  	receptor  	 NN	I-NP
subunits  	subunits  	 NNS	I-NP
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Spier  	Spier  	 NNP	O
et.  	et.  	 NNP	O
al  	al  	 NN	O
.  	.  	 .	O
have  	have  	 VBP	O
suggested  	suggested  	 VBN	O
that  	that  	 IN	O
W183  	W183  	 NNP	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
cation-π  	cation-π  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
group  	group  	 NN	I-NP
of  	of  	 IN	O
5-HT  	5-HT  	 NNP	O
and  	and  	 CC	O
m  	m  	 JJ	B-NP
CPBG  	CPBG  	 NNP	I-NP
[  	[  	 -LRB-	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
If  	If  	 IN	O
W183  	W183  	 NNP	B-NP
and  	and  	 CC	O
Y142  	Y142  	 NNP	B-NP
are  	are  	 VBP	O
located  	located  	 VBN	O
near  	near  	 IN	O
each  	each  	 DT	O
other  	other  	 JJ	O
but  	but  	 CC	O
on  	on  	 IN	O
opposite  	opposite  	 NN	O
faces  	faces  	 VBZ	O
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R 	R 	 NN	O
,  	,  	 ,	O
then  	then  	 RB	O
they  	they  	 PRP	O
could  	could  	 MD	O
potentially  	potentially  	 RB	O
act  	act  	 VB	O
in  	in  	 IN	O
concert  	concert  	 NN	O
to  	to  	 TO	O
help  	help  	 VB	O
stabilize  	stabilize  	 VB	O
a  	a  	 DT	O
conformation  	conformation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
receptor  	receptor  	 NN	I-NP
leading  	leading  	 VBG	O
to  	to  	 TO	O
channel  	channel  	 VB	O
opening.  	opening.  	 CD	O
d  	d  	 SYM	O
-Tubocurarine  	-Tubocurarine  	 JJ	O
inhibition  	inhibition  	 NN	O
was  	was  	 VBD	O
uniquely  	uniquely  	 RB	O
altered  	altered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y140A  	Y140A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
An  	An  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 NN	O
of  	of  	 IN	O
50  	50  	 CD	O
fold  	fold  	 NNS	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
on  	on  	 IN	O
this  	this  	 DT	O
mutant 	mutant 	 NN	B-NP
.  	.  	 .	O
Little  	Little  	 RB	O
if  	if  	 IN	O
any  	any  	 DT	O
change  	change  	 NN	O
resulted  	resulted  	 VBD	O
for  	for  	 IN	O
any  	any  	 DT	O
other  	other  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
Thus 	Thus 	 RB	O
,  	,  	 ,	O
while  	while  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
may  	may  	 MD	O
form  	form  	 VB	O
an  	an  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
at  	at  	 IN	O
this  	this  	 DT	O
binding  	binding  	 JJ	O
loop 	loop 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
Y140  	Y140  	 NNP	B-NP
rather  	rather  	 RB	O
than  	than  	 IN	O
Y142  	Y142  	 NNP	B-NP
or  	or  	 CC	O
Y152 	Y152 	 NNP	B-NP
.  	.  	 .	O
This  	This  	 DT	O
difference  	difference  	 NN	O
in  	in  	 IN	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
interactions  	interactions  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
antagonist  	antagonist  	 JJ	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
and  	and  	 CC	O
the  	the  	 DT	O
agonists  	agonists  	 JJ	O
5-HT  	5-HT  	 NN	O
and  	and  	 CC	O
m  	m  	 JJ	B-NP
CPBG  	CPBG  	 NNP	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
the  	the  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
slightly  	slightly  	 RB	O
different  	different  	 JJ	O
positioning  	positioning  	 NN	O
of  	of  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
antagonists  	antagonists  	 JJ	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
and  	and  	 CC	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
also  	also  	 RB	O
interact  	interact  	 VBN	O
differently  	differently  	 RB	O
with  	with  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
since  	since  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
altered  	altered  	 VBN	O
by  	by  	 IN	O
mutations  	mutations  	 NNS	O
at  	at  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
tested 	tested 	 VBD	O
.  	.  	 .	O
While  	While  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
involve  	involve  	 VB	O
some  	some  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
this  	this  	 DT	O
binding  	binding  	 JJ	O
loop 	loop 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
does  	does  	 VBZ	O
not 	not 	 RB	O
.  	.  	 .	O
Previous  	Previous  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
indicated  	indicated  	 VBN	O
a  	a  	 DT	O
point  	point  	 NN	O
of  	of  	 IN	O
overlap  	overlap  	 NN	O
between  	between  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
and  	and  	 CC	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
at  	at  	 IN	O
W89  	W89  	 CD	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
R.  	R.  	 NNP	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
studies  	studies  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
regions  	regions  	 NNS	O
for  	for  	 IN	O
these  	these  	 DT	O
antagonists  	antagonists  	 NNS	O
are  	are  	 VBP	O
partially  	partially  	 RB	O
overlapping  	overlapping  	 VBG	O
at  	at  	 IN	O
W89  	W89  	 NNP	B-NP
but  	but  	 CC	O
not  	not  	 RB	O
at  	at  	 IN	O
Y140 	Y140 	 CD	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition  	addition  	 NN	B-NP
to  	to  	 TO	O
Y140  	Y140  	 CD	B-NP
and  	and  	 CC	O
W89 	W89 	 NNP	B-NP
,  	,  	 ,	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
has  	has  	 VBZ	O
also  	also  	 RB	O
been  	been  	 VBN	O
observed  	observed  	 VBN	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
D206  	D206  	 NNP	B-NP
and  	and  	 CC	O
several  	several  	 JJ	O
other  	other  	 JJ	O
residues  	residues  	 NNS	O
in  	in  	 IN	O
loop  	loop  	 JJ	O
C  	C  	 NNP	O
[  	[  	 -LRB-	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
involve  	involve  	 VB	O
interaction  	interaction  	 VBN	O
with  	with  	 IN	O
at  	at  	 IN	O
least  	least  	 JJS	O
three  	three  	 CD	O
different  	different  	 JJ	O
binding  	binding  	 JJ	O
loops  	loops  	 NNS	O
( 	( 	 -LRB-	O
A 	A 	 NNP	O
,  	,  	 ,	O
E  	E  	 NNP	O
and  	and  	 CC	O
C 	C 	 NNP	O
)  	)  	 -RRB-	O
although  	although  	 IN	O
additional  	additional  	 JJ	O
interacting  	interacting  	 JJ	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
found 	found 	 VBN	O
.  	.  	 .	O
Data  	Data  	 NNS	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
is  	is  	 VBZ	O
particularly  	particularly  	 RB	O
valuable  	valuable  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
rigid  	rigid  	 JJ	O
nature  	nature  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
molecule 	molecule 	 NN	B-NP
.  	.  	 .	O
Determination  	Determination  	 NN	B-NP
of  	of  	 IN	O
interacting  	interacting  	 JJ	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
and  	and  	 CC	O
their  	their  	 PRP$	O
relationship  	relationship  	 NN	B-NP
to  	to  	 TO	O
individual  	individual  	 JJ	B-NP
amino  	amino  	 JJ	I-NP
acids  	acids  	 NNS	I-NP
could  	could  	 MD	O
enable  	enable  	 VB	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
to  	to  	 TO	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
molecular  	molecular  	 JJ	B-NP
ruler  	ruler  	 NN	I-NP
to  	to  	 TO	O
determine  	determine  	 VB	O
relative  	relative  	 JJ	B-NP
positions  	positions  	 NNS	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
amino  	amino  	 JJ	B-NP
acids 	acids 	 NNS	I-NP
.  	.  	 .	O
Lerisetron  	Lerisetron  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBP	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
mutant  	mutant  	 VB	O
receptors  	receptors  	 NNS	B-NP
was  	was  	 VBD	O
also  	also  	 RB	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
Lerisetron  	Lerisetron  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
potent  	potent  	 JJ	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
antagonist  	antagonist  	 VBZ	I-NP
first  	first  	 JJ	O
synthesized  	synthesized  	 NN	O
by  	by  	 IN	O
Orales  	Orales  	 NNP	B-NP
et.  	et.  	 NNP	O
al.  	al.  	 NNP	O
[  	[  	 -LRB-	O
28  	28  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
As  	As  	 RB	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
agonists 	agonists 	 NN	I-NP
,  	,  	 ,	O
lerisetron  	lerisetron  	 JJ	B-NP
binding  	binding  	 NN	I-NP
was  	was  	 VBD	O
altered  	altered  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Y142A  	Y142A  	 JJ	O
mutation 	mutation 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
mutation  	mutation  	 NN	O
produced  	produced  	 VBD	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
K  	K  	 NNP	O
i  	i  	 NN	O
of  	of  	 IN	O
160  	160  	 CD	O
fold  	fold  	 NNS	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors 	receptors 	 NNS	B-NP
.  	.  	 .	O
This  	This  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
indicates  	indicates  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
lerisetron  	lerisetron  	 NN	B-NP
with  	with  	 IN	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
similarity  	similarity  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
location  	location  	 NN	O
of  	of  	 IN	O
lerisetron 	lerisetron 	 NN	B-NP
,  	,  	 ,	O
5-HT  	5-HT  	 NNP	O
and  	and  	 CC	O
m  	m  	 JJ	B-NP
CPBG 	CPBG 	 NNP	I-NP
.  	.  	 .	O
Lerisetron  	Lerisetron  	 NNP	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
only  	only  	 JJ	O
antagonist  	antagonist  	 NNS	O
tested  	tested  	 VBN	O
that  	that  	 IN	O
shares  	shares  	 NNS	O
a  	a  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
interaction  	interaction  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
with  	with  	 IN	O
agonists 	agonists 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
contrast  	contrast  	 NN	O
to  	to  	 TO	O
5-HT  	5-HT  	 CD	O
and  	and  	 CC	O
m  	m  	 JJ	B-NP
CPBG 	CPBG 	 NNP	I-NP
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
lerisetron  	lerisetron  	 VBD	O
also  	also  	 RB	O
interacts  	interacts  	 VBN	O
with  	with  	 IN	O
Y152  	Y152  	 NNP	B-NP
as  	as  	 RB	O
indicated  	indicated  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
190  	190  	 CD	O
fold  	fold  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
K  	K  	 NNP	O
i  	i  	 FW	O
on  	on  	 FW	O
Y152A  	Y152A  	 FW	O
mutant  	mutant  	 FW	O
receptors 	receptors 	 FW	O
.  	.  	 .	O
Since  	Since  	 IN	O
neither  	neither  	 DT	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
nor  	nor  	 CC	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 JJ	O
interacts  	interacts  	 NN	O
with  	with  	 IN	O
Y142  	Y142  	 NNP	B-NP
or  	or  	 CC	O
Y152 	Y152 	 NNP	B-NP
,  	,  	 ,	O
there  	there  	 EX	O
appears  	appears  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
a  	a  	 DT	O
difference  	difference  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
interactions  	interactions  	 NN	B-NP
formed  	formed  	 VBN	O
by  	by  	 IN	O
these  	these  	 DT	O
antagonists  	antagonists  	 NN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
lerisetron 	lerisetron 	 VB	O
.  	.  	 .	O
The  	The  	 DT	O
binding  	binding  	 JJ	O
sites  	sites  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
three  	three  	 CD	O
antagonists  	antagonists  	 NNS	O
tested  	tested  	 VBD	O
differ  	differ  	 VBN	O
with  	with  	 IN	O
respect  	respect  	 NN	O
to  	to  	 TO	O
this  	this  	 DT	O
binding  	binding  	 JJ	O
loop 	loop 	 NN	O
.  	.  	 .	O
Since  	Since  	 IN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
competitive  	competitive  	 JJ	B-NP
antagonist  	antagonist  	 NN	I-NP
is  	is  	 VBZ	O
simply  	simply  	 RB	O
to  	to  	 TO	O
block  	block  	 VB	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
agonists  	agonists  	 NN	B-NP
and  	and  	 CC	O
prevent  	prevent  	 VB	O
channel  	channel  	 NN	O
opening 	opening 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
that  	that  	 IN	O
interact  	interact  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
ligand  	ligand  	 NN	B-NP
can  	can  	 MD	O
vary  	vary  	 VB	O
for  	for  	 IN	O
different  	different  	 JJ	O
antagonists 	antagonists 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
less  	less  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
be  	be  	 VB	O
the  	the  	 DT	O
case  	case  	 NN	O
with  	with  	 IN	O
agonists  	agonists  	 NN	B-NP
since  	since  	 IN	O
they  	they  	 PRP	O
must  	must  	 MD	O
produce  	produce  	 VB	O
a  	a  	 DT	O
conformational  	conformational  	 JJ	B-NP
change  	change  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
protein  	protein  	 NN	B-NP
to  	to  	 TO	O
exert  	exert  	 VB	O
their  	their  	 PRP$	O
effects 	effects 	 NNS	O
.  	.  	 .	O
Only  	Only  	 RB	O
two  	two  	 CD	O
mutant  	mutant  	 NNS	B-NP
receptors  	receptors  	 VBP	O
failed  	failed  	 VBN	O
to  	to  	 TO	O
bind  	bind  	 VB	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
;  	;  	 :	O
G147A  	G147A  	 CD	O
and  	and  	 CC	O
V149A 	V149A 	 NNP	O
.  	.  	 .	O
G147  	G147  	 NNP	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
conserved  	conserved  	 JJ	O
glycine  	glycine  	 NN	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
putative  	putative  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
loop 	loop 	 NN	I-NP
.  	.  	 .	O
Chirara  	Chirara  	 NNP	B-NP
et.  	et.  	 NNP	O
al.  	al.  	 NNP	O
have  	have  	 VBP	O
suggested  	suggested  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
highly  	highly  	 RB	O
conserved  	conserved  	 JJ	O
nature  	nature  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
glycine  	glycine  	 NN	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
may  	may  	 MD	O
indicate  	indicate  	 VB	O
the  	the  	 DT	O
existence  	existence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
either  	either  	 DT	O
γ  	γ  	 NN	O
or  	or  	 CC	O
a  	a  	 DT	O
loose  	loose  	 JJ	O
three  	three  	 CD	O
residue-turn  	residue-turn  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
nAChR  	nAChR  	 JJ	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Either  	Either  	 RB	O
of  	of  	 IN	O
these  	these  	 DT	O
turns  	turns  	 NNS	O
would  	would  	 MD	O
bring  	bring  	 VB	O
the  	the  	 DT	O
two  	two  	 CD	O
putative  	putative  	 JJ	B-NP
β-strands  	β-strands  	 NN	I-NP
together  	together  	 RB	O
such  	such  	 JJ	O
that  	that  	 IN	O
γL109 	γL109 	 NNP	B-NP
,  	,  	 ,	O
γY111  	γY111  	 NNP	B-NP
and  	and  	 CC	O
γS115  	γS115  	 NNP	B-NP
and  	and  	 CC	O
γY117  	γY117  	 NNP	B-NP
are  	are  	 VBP	O
all  	all  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
side  	side  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
antiparallel  	antiparallel  	 JJ	B-NP
β-sheet 	β-sheet 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
residues  	residues  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
affinity  	affinity  	 JJ	B-NP
labeling 	labeling 	 NN	I-NP
,  	,  	 ,	O
site-directed  	site-directed  	 JJ	O
mutagenesis  	mutagenesis  	 NN	B-NP
or  	or  	 CC	O
cysteine  	cysteine  	 JJ	B-NP
substitution  	substitution  	 NN	I-NP
to  	to  	 TO	O
lie  	lie  	 VB	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
surface 	surface 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
classic  	classic  	 JJ	O
2-residue  	2-residue  	 NNP	O
β-turn  	β-turn  	 NNP	O
would  	would  	 MD	O
place  	place  	 VB	O
these  	these  	 DT	O
residues  	residues  	 NN	O
on  	on  	 IN	O
opposite  	opposite  	 JJ	O
surfaces  	surfaces  	 NNS	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Substitution  	Substitution  	 NNP	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
conserved  	conserved  	 JJ	O
glycine  	glycine  	 NN	B-NP
by  	by  	 IN	O
alanine  	alanine  	 NNS	B-NP
may  	may  	 MD	O
disrupt  	disrupt  	 VB	O
the  	the  	 DT	O
structure  	structure  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
and  	and  	 CC	O
prevent  	prevent  	 VB	O
assembly  	assembly  	 NN	O
or  	or  	 CC	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor 	receptor 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
recent  	recent  	 JJ	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
crystal  	crystal  	 NN	O
structure  	structure  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
AChBP  	AChBP  	 NN	B-NP
supports  	supports  	 VBZ	O
this  	this  	 DT	O
hypothesis 	hypothesis 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
AChBP  	AChBP  	 JJ	B-NP
displays  	displays  	 NNS	I-NP
a  	a  	 DT	O
large  	large  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
homology  	homology  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
terminal  	terminal  	 NN	I-NP
of  	of  	 IN	I-NP
LGIC  	LGIC  	 NNP	I-NP
receptors  	receptors  	 NNS	I-NP
and  	and  	 CC	O
thus  	thus  	 RB	O
may  	may  	 MD	O
be  	be  	 VB	O
similar  	similar  	 JJ	O
in  	in  	 IN	O
structure  	structure  	 NN	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
crystal  	crystal  	 NN	O
structure  	structure  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
protein  	protein  	 NN	B-NP
reveals  	reveals  	 VBZ	O
a  	a  	 DT	O
loose  	loose  	 JJ	O
3  	3  	 CD	O
residue  	residue  	 NNS	O
turn  	turn  	 VBP	O
incorporating  	incorporating  	 VBG	O
the  	the  	 DT	O
conserved  	conserved  	 FW	B-NP
glycine  	glycine  	 FW	I-NP
residue  	residue  	 FW	I-NP
[  	[  	 -LRB-	O
24  	24  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Homologous  	Homologous  	 JJ	B-NP
residues  	residues  	 NNS	I-NP
in  	in  	 IN	O
other  	other  	 JJ	O
LGIC  	LGIC  	 NN	B-NP
subunits  	subunits  	 NNS	I-NP
have  	have  	 VBP	O
also  	also  	 RB	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
and  	and  	 CC	O
are  	are  	 VBP	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
1 	1 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
residues  	residues  	 NN	O
identified  	identified  	 VBN	O
in  	in  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
as  	as  	 IN	O
altering  	altering  	 VBG	O
binding  	binding  	 JJ	O
affinity  	affinity  	 NN	B-NP
of  	of  	 IN	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	B-NP
ligands  	ligands  	 NNS	I-NP
would  	would  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
present  	present  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
surface  	surface  	 NN	O
if  	if  	 IN	O
this  	this  	 DT	O
structure  	structure  	 NN	O
is  	is  	 VBZ	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R.  	R.  	 NNP	O
While  	While  	 IN	O
Y140  	Y140  	 NNP	B-NP
lies  	lies  	 VBZ	O
somewhat  	somewhat  	 RB	O
outside  	outside  	 IN	O
the  	the  	 DT	O
region  	region  	 NN	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
Chiara  	Chiara  	 NNP	O
in  	in  	 IN	O
the  	the  	 DT	O
nAChR  	nAChR  	 JJ	O
( 	( 	 -LRB-	O
homologous  	homologous  	 RB	O
to  	to  	 TO	O
γN107 	γN107 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
γL109  	γL109  	 NNP	B-NP
and  	and  	 CC	O
γL119  	γL119  	 NNP	B-NP
are  	are  	 VBP	O
homologous  	homologous  	 VBN	O
to  	to  	 TO	O
Y142  	Y142  	 CD	B-NP
and  	and  	 CC	O
Y152  	Y152  	 CD	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
R.  	R.  	 NNP	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
lerisetron  	lerisetron  	 VBG	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
both  	both  	 DT	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 NNP	B-NP
also  	also  	 RB	O
supports  	supports  	 VBZ	O
the  	the  	 DT	O
hypothesis  	hypothesis  	 NN	O
that  	that  	 IN	O
these  	these  	 DT	O
two  	two  	 CD	O
amino  	amino  	 CD	B-NP
acids  	acids  	 NNS	I-NP
are  	are  	 VBP	O
present  	present  	 JJ	O
in  	in  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
since  	since  	 IN	O
the  	the  	 DT	O
eight  	eight  	 CD	O
intervening  	intervening  	 CD	B-NP
residues  	residues  	 NNS	I-NP
would  	would  	 MD	O
position  	position  	 VB	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 NNP	B-NP
too  	too  	 RB	O
far  	far  	 RB	O
apart  	apart  	 RB	O
to  	to  	 TO	O
permit  	permit  	 VB	O
them  	them  	 PRP	O
both  	both  	 VBP	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
ligand  	ligand  	 NNS	B-NP
even  	even  	 RB	O
if  	if  	 IN	O
they  	they  	 PRP	O
were  	were  	 VBD	O
interacting  	interacting  	 VBN	O
with  	with  	 IN	O
functional  	functional  	 JJ	B-NP
groups  	groups  	 NNS	I-NP
on  	on  	 IN	O
opposite  	opposite  	 JJ	O
ends  	ends  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
molecule 	molecule 	 NN	B-NP
.  	.  	 .	O
A  	A  	 DT	O
loop  	loop  	 JJ	O
structure  	structure  	 NN	O
would  	would  	 MD	O
bring  	bring  	 VB	O
them  	them  	 PRP	O
into  	into  	 IN	O
closer  	closer  	 JJR	O
proximity  	proximity  	 NNS	O
and  	and  	 CC	O
permit  	permit  	 VB	O
interaction  	interaction  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
small  	small  	 JJ	O
molecule  	molecule  	 NN	B-NP
lerisetron 	lerisetron 	 NN	I-NP
.  	.  	 .	O
All  	All  	 DT	O
three  	three  	 CD	O
tyrosine  	tyrosine  	 CD	B-NP
mutations  	mutations  	 NNS	I-NP
were  	were  	 VBD	O
investigated  	investigated  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
patch  	patch  	 NN	O
clamp  	clamp  	 VBZ	O
assay  	assay  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
functional  	functional  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
observed 	observed 	 VBN	O
.  	.  	 .	O
Whole  	Whole  	 JJ	O
cell  	cell  	 NN	O
responses  	responses  	 NNS	O
could  	could  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
obtained  	obtained  	 VBN	O
for  	for  	 IN	O
Y140A  	Y140A  	 NNP	O
or  	or  	 CC	O
Y142A 	Y142A 	 NNP	O
,  	,  	 ,	O
although  	although  	 IN	O
specific  	specific  	 JJ	O
binding  	binding  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
was  	was  	 VBD	O
observed 	observed 	 VBN	O
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
suggest  	suggest  	 VBP	O
that 	that 	 RB	O
,  	,  	 ,	O
while  	while  	 IN	O
the  	the  	 DT	O
receptors  	receptors  	 NNS	B-NP
do  	do  	 VBP	O
assemble  	assemble  	 VBN	O
and  	and  	 CC	O
are  	are  	 VBP	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
binding  	binding  	 JJ	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron 	granisetron 	 NN	B-NP
,  	,  	 ,	O
they  	they  	 PRP	O
are  	are  	 VBP	O
either  	either  	 RB	O
not  	not  	 RB	O
transported  	transported  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
cell  	cell  	 NN	O
surface  	surface  	 NN	O
or  	or  	 CC	O
are  	are  	 VBP	O
non-responsive  	non-responsive  	 JJ	B-NP
to  	to  	 TO	O
5-HT  	5-HT  	 CD	O
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	O
1  	1  	 CD	O
mM  	mM  	 JJ	O
or  	or  	 CC	O
less 	less 	 JJR	O
.  	.  	 .	O
Y152A  	Y152A  	 NNP	O
does  	does  	 VBZ	O
produce  	produce  	 VB	O
functional  	functional  	 JJ	B-NP
channels  	channels  	 NNS	I-NP
however  	however  	 RB	O
they  	they  	 PRP	O
display  	display  	 VBP	O
distinctly  	distinctly  	 RB	O
altered  	altered  	 VBN	B-NP
response  	response  	 NN	I-NP
kinetics  	kinetics  	 NN	I-NP
when  	when  	 WRB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wildtype  	wildtype  	 VB	O
receptors 	receptors 	 NNS	B-NP
.  	.  	 .	O
Y152A  	Y152A  	 NNP	O
responses  	responses  	 NNS	O
do  	do  	 VBP	O
not  	not  	 RB	O
show  	show  	 VB	O
the  	the  	 DT	O
rapid  	rapid  	 JJ	B-NP
rise  	rise  	 NN	I-NP
times  	times  	 NNS	I-NP
observed  	observed  	 VBD	O
in  	in  	 IN	O
wt  	wt  	 JJ	B-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
extremely  	extremely  	 RB	O
slow  	slow  	 JJ	O
rise  	rise  	 NN	B-NP
times  	times  	 NNS	I-NP
observed  	observed  	 VBD	O
for  	for  	 IN	O
Y152A  	Y152A  	 CD	O
receptors  	receptors  	 NNS	O
may  	may  	 MD	O
indicate  	indicate  	 VB	O
a  	a  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
rate  	rate  	 NN	B-NP
constants  	constants  	 VBZ	I-NP
preceding  	preceding  	 VBG	O
channel  	channel  	 NN	O
opening 	opening 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
rate  	rate  	 NN	B-NP
constants  	constants  	 NN	I-NP
for  	for  	 IN	O
either  	either  	 DT	O
agonist  	agonist  	 JJ	B-NP
binding  	binding  	 NN	I-NP
or  	or  	 CC	O
channel  	channel  	 VB	O
opening  	opening  	 VBG	O
also  	also  	 RB	O
produce  	produce  	 VB	O
a  	a  	 DT	O
140  	140  	 CD	O
fold  	fold  	 JJ	O
decrease  	decrease  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
observed  	observed  	 JJ	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
for  	for  	 IN	O
5-HT  	5-HT  	 CD	O
activation 	activation 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
slow  	slow  	 JJ	O
rise  	rise  	 NN	O
is  	is  	 VBZ	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
non-desensitizing  	non-desensitizing  	 JJ	B-NP
phase  	phase  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
response  	response  	 NN	O
that  	that  	 WDT	O
is  	is  	 VBZ	O
dramatically  	dramatically  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
the  	the  	 DT	O
fast  	fast  	 JJ	O
desensitization  	desensitization  	 NN	B-NP
observed  	observed  	 VBD	O
for  	for  	 IN	O
wt  	wt  	 JJ	O
5-HT  	5-HT  	 NNP	O
3AS  	3AS  	 NNP	O
Rs 	Rs 	 NNP	O
.  	.  	 .	O
Lack  	Lack  	 NN	O
of  	of  	 IN	O
desensitization  	desensitization  	 NNS	B-NP
could  	could  	 MD	O
result  	result  	 VB	O
from  	from  	 IN	O
either  	either  	 RB	O
a  	a  	 DT	O
stabilization  	stabilization  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
open  	open  	 JJ	O
state  	state  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
channel  	channel  	 NN	O
or  	or  	 CC	O
a  	a  	 DT	O
destabilization  	destabilization  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
desensitized  	desensitized  	 JJ	O
state 	state 	 NN	O
.  	.  	 .	O
Mutations  	Mutations  	 NNS	O
of  	of  	 IN	O
homologous  	homologous  	 NN	B-NP
or  	or  	 CC	O
nearby  	nearby  	 JJ	O
residues  	residues  	 NNS	O
in  	in  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
nAChR  	nAChR  	 JJ	O
and  	and  	 CC	O
GABA  	GABA  	 NNP	B-NP
A  	A  	 NNP	O
receptors  	receptors  	 NNS	B-NP
have  	have  	 VBP	O
also  	also  	 RB	O
been  	been  	 VBN	O
demonstrated  	demonstrated  	 VBN	O
to  	to  	 TO	O
alter  	alter  	 VB	O
the  	the  	 DT	O
agonist  	agonist  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
homologous  	homologous  	 JJ	B-NP
residue  	residue  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
GABA  	GABA  	 NNP	B-NP
A  	A  	 DT	O
receptor  	receptor  	 NN	B-NP
γ-subunit  	γ-subunit  	 NNS	I-NP
( 	( 	 -LRB-	O
T142 	T142 	 NNP	B-NP
)  	)  	 -RRB-	O
to  	to  	 TO	O
serine  	serine  	 VB	O
altered  	altered  	 VBN	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
agonist  	agonist  	 JJ	B-NP
Flumazenil 	Flumazenil 	 NNP	I-NP
,  	,  	 ,	O
converting  	converting  	 VBG	O
it  	it  	 PRP	O
to  	to  	 TO	O
a  	a  	 DT	O
partial  	partial  	 JJ	O
agonist  	agonist  	 NNS	B-NP
[  	[  	 -LRB-	O
29  	29  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
nAChR 	nAChR 	 JJ	O
,  	,  	 ,	O
mutation  	mutation  	 NN	O
of  	of  	 IN	O
mouse  	mouse  	 NN	O
and  	and  	 CC	O
rat  	rat  	 CD	B-NP
εP121  	εP121  	 CD	I-NP
to  	to  	 TO	O
leucine  	leucine  	 VB	O
altered  	altered  	 VBN	O
both  	both  	 PDT	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
acetylcholine  	acetylcholine  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
stability  	stability  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
open  	open  	 JJ	O
state  	state  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
channel.  	channel.  	 NNP	O
εP121  	εP121  	 NNP	B-NP
is  	is  	 VBZ	O
homologous  	homologous  	 VBN	O
to  	to  	 TO	O
P154  	P154  	 CD	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
and  	and  	 CC	O
is  	is  	 VBZ	O
only  	only  	 RB	O
two  	two  	 CD	O
residues  	residues  	 NNS	O
away  	away  	 RB	O
from  	from  	 IN	O
Y152 	Y152 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
authors  	authors  	 NNS	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
concluded  	concluded  	 VBD	O
that  	that  	 IN	O
this  	this  	 DT	O
portion  	portion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
acetylcholine  	acetylcholine  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
site  	site  	 NN	I-NP
was  	was  	 VBD	O
closely  	closely  	 RB	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
channel  	channel  	 NN	O
opening  	opening  	 NN	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
[  	[  	 -LRB-	O
30  	30  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
reasonable  	reasonable  	 JJ	O
to  	to  	 TO	O
conclude  	conclude  	 VB	O
that  	that  	 IN	O
the  	the  	 DT	O
homologous  	homologous  	 JJ	B-NP
region  	region  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
may  	may  	 MD	O
perform  	perform  	 VB	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
function 	function 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
link  	link  	 NN	O
between  	between  	 IN	O
an  	an  	 DT	O
agonist  	agonist  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
domain  	domain  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
conformational  	conformational  	 JJ	B-NP
change  	change  	 NN	I-NP
leading  	leading  	 VBG	O
to  	to  	 TO	O
channel  	channel  	 VB	O
opening  	opening  	 NN	O
is  	is  	 VBZ	O
not  	not  	 RB	O
unexpected  	unexpected  	 JJ	O
since  	since  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
must  	must  	 MD	O
obviously  	obviously  	 RB	O
be  	be  	 VB	O
linked 	linked 	 VBN	O
.  	.  	 .	O
If  	If  	 IN	O
binding  	binding  	 VBG	O
to  	to  	 TO	O
this  	this  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
is  	is  	 VBZ	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
a  	a  	 DT	O
critical  	critical  	 JJ	B-NP
step  	step  	 NN	I-NP
between  	between  	 IN	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
agonists  	agonists  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
opening  	opening  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
channel 	channel 	 NN	O
,  	,  	 ,	O
further  	further  	 JJ	O
investigation  	investigation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
amino  	amino  	 JJ	I-NP
acids  	acids  	 NNS	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
loop  	loop  	 NN	O
may  	may  	 MD	O
provide  	provide  	 VB	O
valuable  	valuable  	 JJ	O
clues  	clues  	 NNS	O
to  	to  	 TO	O
molecular  	molecular  	 JJ	B-NP
basis  	basis  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
process 	process 	 NN	O
.  	.  	 .	O
Conclusions  	Conclusions  	 VBG	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
indicate  	indicate  	 VBP	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
for  	for  	 IN	O
this  	this  	 DT	O
putative  	putative  	 JJ	B-NP
binding  	binding  	 JJ	I-NP
site  	site  	 NN	I-NP
loop  	loop  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R  	R  	 NN	O
with  	with  	 IN	O
different  	different  	 JJ	O
ligands  	ligands  	 NN	B-NP
and  	and  	 CC	O
illustrate  	illustrate  	 VB	O
the  	the  	 DT	O
difference  	difference  	 NN	O
in  	in  	 IN	O
binding  	binding  	 VBG	O
of  	of  	 IN	O
different  	different  	 JJ	O
structural  	structural  	 JJ	B-NP
classes  	classes  	 NNS	I-NP
of  	of  	 IN	I-NP
ligands 	ligands 	 NN	I-NP
.  	.  	 .	O
Each  	Each  	 DT	O
structural  	structural  	 JJ	B-NP
class  	class  	 NN	I-NP
shows  	shows  	 VBZ	O
different  	different  	 JJ	O
patterns  	patterns  	 NNS	O
of  	of  	 IN	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor.  	receptor.  	 NNP	B-NP
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
does  	does  	 VBZ	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
any  	any  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
tested  	tested  	 VBN	O
while  	while  	 IN	O
d  	d  	 JJ	O
-tc  	-tc  	 JJ	O
interacts  	interacts  	 NN	O
with  	with  	 IN	O
only  	only  	 RB	O
Y140 	Y140 	 CD	B-NP
,  	,  	 ,	O
m  	m  	 VBG	O
CPBG  	CPBG  	 NNP	B-NP
and  	and  	 CC	O
5-HT  	5-HT  	 CD	O
with  	with  	 IN	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
lerisetron  	lerisetron  	 NN	B-NP
with  	with  	 IN	O
both  	both  	 DT	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152 	Y152 	 NNP	B-NP
.  	.  	 .	O
Similar  	Similar  	 JJ	B-NP
selective  	selective  	 JJ	I-NP
effects  	effects  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
observed  	observed  	 VBN	O
on  	on  	 IN	O
other  	other  	 JJ	O
residues  	residues  	 NNS	O
including  	including  	 VBG	B-NP
W183 	W183 	 NNP	I-NP
,  	,  	 ,	O
W89 	W89 	 NNP	B-NP
,  	,  	 ,	O
F107  	F107  	 NNP	B-NP
and  	and  	 CC	O
E106  	E106  	 CD	B-NP
among  	among  	 IN	O
others  	others  	 NNS	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
21  	21  	 CD	O
25  	25  	 CD	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
data  	data  	 NNS	O
in  	in  	 IN	O
conjunction  	conjunction  	 NN	O
with  	with  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
other  	other  	 JJ	O
laboratories  	laboratories  	 NNS	O
indicates  	indicates  	 VBZ	O
the  	the  	 DT	O
differences  	differences  	 NNS	O
in  	in  	 IN	O
orientation  	orientation  	 NN	O
of  	of  	 IN	O
different  	different  	 JJ	O
ligands  	ligands  	 NN	B-NP
within  	within  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
binding  	binding  	 JJ	O
cleft 	cleft 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
differences  	differences  	 NNS	O
in  	in  	 IN	O
orientation  	orientation  	 JJ	B-NP
result  	result  	 NN	I-NP
in  	in  	 IN	O
different  	different  	 JJ	O
amino  	amino  	 JJ	B-NP
acid 	acid 	 NN	I-NP
/ 	/ 	 CD	I-NP
functional  	functional  	 JJ	I-NP
group  	group  	 NN	I-NP
interactions 	interactions 	 NNS	I-NP
.  	.  	 .	O
As  	As  	 IN	O
the  	the  	 DT	O
structural  	structural  	 JJ	B-NP
detail  	detail  	 NN	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
interactions  	interactions  	 NN	B-NP
emerges 	emerges 	 VBZ	O
,  	,  	 ,	O
these  	these  	 DT	O
differences  	differences  	 NNS	O
could  	could  	 MD	O
potentially  	potentially  	 RB	O
be  	be  	 VB	O
exploited  	exploited  	 VBN	O
to  	to  	 TO	O
produce  	produce  	 VB	O
more  	more  	 RBR	O
potent  	potent  	 JJ	O
and  	and  	 CC	O
specific  	specific  	 JJ	O
ligands 	ligands 	 NN	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example  	example  	 NN	B-NP
construction  	construction  	 NN	I-NP
of  	of  	 IN	O
a  	a  	 DT	O
"hybrid 	"hybrid 	 NN	O
"  	"  	 ''	O
ligand  	ligand  	 NNS	B-NP
that  	that  	 WDT	O
combines  	combines  	 VBZ	O
the  	the  	 DT	O
interactions  	interactions  	 NN	B-NP
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	B-NP
with  	with  	 IN	O
those  	those  	 DT	O
of  	of  	 IN	O
d  	d  	 JJ	O
-tc 	-tc 	 NN	O
,  	,  	 ,	O
5-HT  	5-HT  	 NNP	O
or  	or  	 CC	O
m  	m  	 JJ	B-NP
CPBG  	CPBG  	 NNP	I-NP
could  	could  	 MD	O
produce  	produce  	 VB	O
an  	an  	 DT	O
antagonist  	antagonist  	 NN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
affinity  	affinity  	 JJ	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
additional  	additional  	 JJ	O
binding  	binding  	 JJ	O
energy  	energy  	 NN	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
interactions  	interactions  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
greater  	greater  	 JJR	O
specificity  	specificity  	 NN	O
since  	since  	 IN	O
it  	it  	 PRP	O
would  	would  	 MD	O
utilize  	utilize  	 VB	O
more  	more  	 RBR	O
structural  	structural  	 JJ	B-NP
features  	features  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
requirement  	requirement  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
glycine  	glycine  	 NN	B-NP
at  	at  	 IN	O
position  	position  	 NN	O
147  	147  	 CD	O
and  	and  	 CC	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	O
lerisetron  	lerisetron  	 VBG	O
to  	to  	 TO	O
interact  	interact  	 VB	O
with  	with  	 IN	O
both  	both  	 DT	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 NNP	B-NP
also  	also  	 RB	O
support  	support  	 VB	O
the  	the  	 DT	O
hypothesis  	hypothesis  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
secondary  	secondary  	 JJ	B-NP
structure  	structure  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
region  	region  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
receptor  	receptor  	 NN	B-NP
is  	is  	 VBZ	O
formed  	formed  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
loop  	loop  	 JJ	O
structure 	structure 	 NN	O
.  	.  	 .	O
If  	If  	 IN	O
the  	the  	 DT	O
loose  	loose  	 JJ	O
3  	3  	 CD	O
residue  	residue  	 NNS	O
turn  	turn  	 VBP	O
proposed  	proposed  	 VBN	O
by  	by  	 IN	O
Chiara  	Chiara  	 NNP	O
et.  	et.  	 NNP	O
al.  	al.  	 NNP	O
and  	and  	 CC	O
shown  	shown  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
AChBP  	AChBP  	 NN	B-NP
is  	is  	 VBZ	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
5-HT  	5-HT  	 CD	O
3  	3  	 CD	O
R 	R 	 NN	O
,  	,  	 ,	O
then  	then  	 RB	O
Y140 	Y140 	 CD	B-NP
,  	,  	 ,	O
Y142  	Y142  	 NNP	B-NP
and  	and  	 CC	O
Y152  	Y152  	 NNP	B-NP
would  	would  	 MD	O
be  	be  	 VB	O
present  	present  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
side  	side  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
sheet  	sheet  	 NN	O
and  	and  	 CC	O
all  	all  	 DT	O
three  	three  	 CD	O
would  	would  	 MD	O
be  	be  	 VB	O
capable  	capable  	 JJ	O
of  	of  	 IN	O
extending  	extending  	 VBG	O
into  	into  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site 	site 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
similar  	similar  	 JJ	O
observation  	observation  	 NN	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
made  	made  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
nAChR  	nAChR  	 JJ	O
where  	where  	 WRB	O
γS111 	γS111 	 NNP	B-NP
,  	,  	 ,	O
γY117 	γY117 	 NNP	B-NP
,  	,  	 ,	O
γL119 	γL119 	 NNP	B-NP
,  	,  	 ,	O
δR113  	δR113  	 NNP	B-NP
and  	and  	 CC	O
δT119  	δT119  	 CD	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
mouse  	mouse  	 JJ	O
nAChR  	nAChR  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
and  	and  	 CC	O
γL109  	γL109  	 NNP	B-NP
and  	and  	 CC	O
γY111  	γY111  	 CD	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
torpedo  	torpedo  	 JJ	I-NP
nAChR  	nAChR  	 NNS	I-NP
are  	are  	 VBP	O
all  	all  	 RB	O
thought  	thought  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
present  	present  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
site  	site  	 NN	O
[  	[  	 -LRB-	O
12  	12  	 CD	O
13  	13  	 CD	O
14  	14  	 CD	O
15  	15  	 CD	O
16  	16  	 CD	O
17  	17  	 CD	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Materials  	Materials  	 NNS	O
and  	and  	 CC	O
Methods  	Methods  	 NNP	O
Materials  	Materials  	 NNPS	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	O
was  	was  	 VBD	O
purchased  	purchased  	 VBN	O
from  	from  	 IN	O
New  	New  	 NNP	O
England  	England  	 NNP	O
Nuclear 	Nuclear 	 NNP	O
,  	,  	 ,	O
5-HT  	5-HT  	 NNP	O
from  	from  	 IN	O
Spectrum 	Spectrum 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
m  	m  	 JJ	O
CPBG  	CPBG  	 NNP	O
and  	and  	 CC	O
d  	d  	 JJ	O
-tc  	-tc  	 NN	O
from  	from  	 IN	O
Research  	Research  	 NNP	O
Biochemical  	Biochemical  	 NNP	O
International 	International 	 NNP	O
.  	.  	 .	O
Lerisetron  	Lerisetron  	 NNP	O
was  	was  	 VBD	O
provided  	provided  	 VBN	O
by  	by  	 IN	O
Dr.  	Dr.  	 NNP	O
Karen  	Karen  	 NNP	O
Kirschbaum  	Kirschbaum  	 NNP	O
at  	at  	 IN	O
The  	The  	 DT	O
University  	University  	 NNP	O
of  	of  	 IN	O
Louisiana  	Louisiana  	 NNP	O
at  	at  	 IN	O
Monroe 	Monroe 	 NNP	O
,  	,  	 ,	O
Monroe 	Monroe 	 NNP	O
,  	,  	 ,	O
LA 	LA 	 NNP	O
.  	.  	 .	O
All  	All  	 DT	O
other  	other  	 JJ	O
reagents  	reagents  	 NN	O
were  	were  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
commercial  	commercial  	 JJ	O
sources 	sources 	 NNS	O
.  	.  	 .	O
Site  	Site  	 FW	O
directed  	directed  	 FW	B-NP
mutagenesis  	mutagenesis  	 FW	I-NP
Wild  	Wild  	 FW	O
type  	type  	 FW	O
5-HT  	5-HT  	 FW	O
3AS  	3AS  	 FW	O
mouse  	mouse  	 FW	O
receptor  	receptor  	 FW	O
cDNA  	cDNA  	 NNP	O
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
Dr.  	Dr.  	 NNP	B-NP
Michael  	Michael  	 NNP	O
White  	White  	 NNP	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Mutant  	Mutant  	 JJ	B-NP
receptors  	receptors  	 NNS	I-NP
were  	were  	 VBD	O
constructed  	constructed  	 VBN	O
using  	using  	 VBG	O
either  	either  	 RB	O
the  	the  	 DT	O
Quick  	Quick  	 NNP	O
Change  	Change  	 NNP	B-NP
Mutagenesis  	Mutagenesis  	 NNP	I-NP
kit  	kit  	 NN	I-NP
( 	( 	 -LRB-	O
Stratagene 	Stratagene 	 NNP	B-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
the  	the  	 DT	O
Altered  	Altered  	 NNP	O
Sites  	Sites  	 NNP	O
Mutagenesis  	Mutagenesis  	 NNP	B-NP
kit  	kit  	 NN	I-NP
( 	( 	 -LRB-	O
Promega 	Promega 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
mutations  	mutations  	 NN	O
were  	were  	 VBD	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
commercial  	commercial  	 JJ	B-NP
DNA  	DNA  	 NN	I-NP
sequencing 	sequencing 	 NN	I-NP
.  	.  	 .	O
Cell  	Cell  	 NN	O
culture  	culture  	 NN	O
and  	and  	 CC	O
transfection  	transfection  	 CD	O
tsA201  	tsA201  	 CD	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
a  	a  	 DT	O
derivative  	derivative  	 JJ	O
of  	of  	 IN	O
HEK293  	HEK293  	 CD	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
were  	were  	 VBD	O
seeded  	seeded  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
5  	5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6cells 	6cells 	 CD	O
/ 	/ 	 CD	O
100  	100  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
grown  	grown  	 VBN	O
in  	in  	 IN	O
DMEM  	DMEM  	 NNP	O
medium  	medium  	 NN	O
containing  	containing  	 VBG	O
10 	10 	 CD	O
%  	%  	 NN	O
FBS 	FBS 	 NNP	O
,  	,  	 ,	O
100  	100  	 CD	O
units 	units 	 NNS	O
/ 	/ 	 SYM	O
ml  	ml  	 FW	O
penicillin 	penicillin 	 FW	O
/ 	/ 	 FW	O
streptomycin  	streptomycin  	 FW	O
for  	for  	 IN	O
nine  	nine  	 CD	O
hours  	hours  	 NNS	O
in  	in  	 IN	O
5 	5 	 CD	O
%  	%  	 NN	O
CO  	CO  	 NNP	O
2  	2  	 CD	O
and  	and  	 CC	O
transfected  	transfected  	 NN	O
with  	with  	 IN	O
10  	10  	 CD	O
μg  	μg  	 CD	O
mouse  	mouse  	 CD	O
5-HT  	5-HT  	 CD	O
3AS  	3AS  	 CD	O
R  	R  	 NN	O
cDNA  	cDNA  	 NN	O
per  	per  	 IN	O
100  	100  	 CD	O
mm  	mm  	 NNS	O
dish  	dish  	 VBP	O
using  	using  	 VBG	O
the  	the  	 DT	O
calcium  	calcium  	 JJ	O
phosphate  	phosphate  	 JJ	O
technique  	technique  	 NN	O
( 	( 	 -LRB-	O
New  	New  	 NNP	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
,  	,  	 ,	O
NY 	NY 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Media  	Media  	 NNS	O
was  	was  	 VBD	O
changed  	changed  	 VBN	O
12-14  	12-14  	 CD	O
hrs  	hrs  	 NN	O
after  	after  	 IN	O
transfection 	transfection 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
allowed  	allowed  	 VBN	O
to  	to  	 TO	O
grow  	grow  	 VB	O
for  	for  	 IN	O
another  	another  	 DT	O
24  	24  	 CD	O
hours  	hours  	 NNS	O
and  	and  	 CC	O
then  	then  	 RB	O
harvested 	harvested 	 VBN	O
.  	.  	 .	O
For  	For  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
patch  	patch  	 NN	O
clamp  	clamp  	 NN	O
experiments 	experiments 	 NNS	O
,  	,  	 ,	O
tsA201  	tsA201  	 CD	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
seeded  	seeded  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
density  	density  	 NN	O
of  	of  	 IN	O
0.25  	0.25  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6cells 	6cells 	 CD	O
/ 	/ 	 CD	O
60  	60  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
grown  	grown  	 VBN	O
in  	in  	 IN	O
DMEM  	DMEM  	 NNP	B-NP
culture  	culture  	 NN	I-NP
medium  	medium  	 NN	I-NP
containing  	containing  	 VBG	O
10 	10 	 CD	O
%  	%  	 NN	O
FBS  	FBS  	 NNP	B-NP
and  	and  	 CC	O
100  	100  	 CD	O
units 	units 	 NNS	B-NP
/ 	/ 	 SYM	I-NP
ml  	ml  	 FW	I-NP
penicillin 	penicillin 	 FW	I-NP
/ 	/ 	 FW	I-NP
streptomycin  	streptomycin  	 FW	I-NP
for  	for  	 IN	O
12  	12  	 CD	O
hours  	hours  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
transfection 	transfection 	 VB	O
.  	.  	 .	O
Transfections  	Transfections  	 NNP	B-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
Superfect  	Superfect  	 NNP	B-NP
Transfection  	Transfection  	 NNP	I-NP
Reagent  	Reagent  	 NNP	I-NP
( 	( 	 -LRB-	O
Qiagen 	Qiagen 	 NNP	B-NP
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Ten  	Ten  	 CD	O
μg  	μg  	 NN	B-NP
of  	of  	 IN	I-NP
cDNA  	cDNA  	 NNP	I-NP
were  	were  	 VBD	O
mixed  	mixed  	 VBN	O
with  	with  	 IN	O
DMEM  	DMEM  	 NNP	B-NP
medium  	medium  	 NN	I-NP
containing  	containing  	 VBG	O
no  	no  	 DT	O
serum  	serum  	 NN	B-NP
or  	or  	 CC	O
antibiotics  	antibiotics  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
volume  	volume  	 NN	O
of  	of  	 IN	O
150  	150  	 CD	O
μl 	μl 	 NNS	B-NP
.  	.  	 .	O
Twenty  	Twenty  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
Superfect  	Superfect  	 NNP	I-NP
reagent  	reagent  	 NN	I-NP
were  	were  	 VBD	O
then  	then  	 RB	O
added  	added  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
mixture  	mixture  	 NN	B-NP
incubated  	incubated  	 NN	I-NP
at  	at  	 IN	O
room  	room  	 NN	B-NP
temperature  	temperature  	 NN	I-NP
for  	for  	 IN	O
15  	15  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
reaction  	reaction  	 NN	O
was  	was  	 VBD	O
terminated  	terminated  	 VBN	O
by  	by  	 IN	O
adding  	adding  	 VBG	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
DMEM  	DMEM  	 NNP	B-NP
medium  	medium  	 NN	I-NP
containing  	containing  	 VBG	O
10 	10 	 CD	O
%  	%  	 NN	O
FBS  	FBS  	 NNP	B-NP
and  	and  	 CC	O
100  	100  	 CD	O
units 	units 	 NNS	B-NP
/ 	/ 	 SYM	I-NP
ml  	ml  	 FW	I-NP
penicillin 	penicillin 	 FW	I-NP
/ 	/ 	 FW	I-NP
streptomycin  	streptomycin  	 FW	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
mixture  	mixture  	 NN	O
added  	added  	 VBD	O
to  	to  	 TO	O
cells  	cells  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
60  	60  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
Superfect  	Superfect  	 NNP	B-NP
Reagent  	Reagent  	 NNP	I-NP
for  	for  	 IN	O
3  	3  	 CD	O
hours 	hours 	 NNS	O
.  	.  	 .	O
At  	At  	 IN	O
that  	that  	 DT	O
time 	time 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
reagent  	reagent  	 NN	B-NP
was  	was  	 VBD	O
replaced  	replaced  	 VBN	O
with  	with  	 IN	O
DMEM  	DMEM  	 NNP	B-NP
medium  	medium  	 NN	I-NP
containing  	containing  	 VBG	O
10 	10 	 CD	O
%  	%  	 NN	O
FBS  	FBS  	 NNP	B-NP
and  	and  	 CC	O
100  	100  	 CD	O
units 	units 	 NNS	B-NP
/ 	/ 	 SYM	I-NP
ml  	ml  	 FW	I-NP
penicillin 	penicillin 	 FW	I-NP
/ 	/ 	 FW	I-NP
streptomycin  	streptomycin  	 FW	I-NP
and  	and  	 CC	O
incubated  	incubated  	 NN	O
for  	for  	 IN	O
an  	an  	 DT	O
additional  	additional  	 JJ	O
24  	24  	 CD	O
hours  	hours  	 NNS	O
prior  	prior  	 RB	O
to  	to  	 TO	O
use 	use 	 VB	O
.  	.  	 .	O
Binding  	Binding  	 JJ	O
assays  	assays  	 JJ	O
Transfected  	Transfected  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
were  	were  	 VBD	O
scraped  	scraped  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
dishes 	dishes 	 NNS	O
,  	,  	 ,	O
washed  	washed  	 VBD	O
twice  	twice  	 RB	O
with  	with  	 IN	O
Dulbecco 	Dulbecco 	 NNP	O
's  	's  	 POS	O
PBS  	PBS  	 NNP	B-NP
( 	( 	 -LRB-	O
New  	New  	 NNP	O
Life  	Life  	 NNP	O
Technologies 	Technologies 	 NNPS	O
,  	,  	 ,	O
NY 	NY 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
then  	then  	 RB	O
resuspended  	resuspended  	 VBN	O
in  	in  	 IN	O
1.0  	1.0  	 CD	O
ml  	ml  	 JJ	B-NP
ice  	ice  	 NN	I-NP
cold  	cold  	 JJ	O
PBS 	PBS 	 NNP	B-NP
/ 	/ 	 CD	O
100  	100  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
either  	either  	 RB	O
used  	used  	 VBN	O
fresh  	fresh  	 JJ	O
or  	or  	 CC	O
frozen  	frozen  	 VBN	O
at  	at  	 IN	O
this  	this  	 DT	O
step  	step  	 NN	O
until  	until  	 IN	O
needed 	needed 	 VBN	O
.  	.  	 .	O
Immediately  	Immediately  	 RB	O
prior  	prior  	 RB	O
to  	to  	 TO	O
use 	use 	 VB	O
,  	,  	 ,	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
homogenized  	homogenized  	 VBN	O
on  	on  	 IN	O
ice  	ice  	 NN	O
in  	in  	 IN	O
PBS  	PBS  	 NNP	B-NP
using  	using  	 VBG	O
a  	a  	 DT	O
glass  	glass  	 NN	O
tissue  	tissue  	 NN	O
homogenizer  	homogenizer  	 VBZ	O
then  	then  	 RB	O
centrifuged  	centrifuged  	 VBN	O
at  	at  	 IN	O
35  	35  	 CD	O
000  	000  	 CD	O
×  	×  	 CD	O
g  	g  	 NN	O
for  	for  	 IN	O
30  	30  	 CD	O
minutes  	minutes  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
Beckman  	Beckman  	 NNP	B-NP
JA20  	JA20  	 FW	I-NP
rotor  	rotor  	 FW	I-NP
( 	( 	 -LRB-	O
4°C 	4°C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Membranes  	Membranes  	 NNP	O
were  	were  	 VBD	O
washed  	washed  	 VBN	O
once  	once  	 RB	O
more  	more  	 JJR	O
with  	with  	 IN	O
PBS  	PBS  	 NNP	B-NP
at  	at  	 IN	O
4°C  	4°C  	 NNP	O
then  	then  	 RB	O
resuspended  	resuspended  	 VBN	O
in  	in  	 IN	O
1  	1  	 CD	O
ml  	ml  	 JJ	B-NP
PBS 	PBS 	 NNP	I-NP
/ 	/ 	 CD	O
100  	100  	 CD	O
mm  	mm  	 JJ	O
dish 	dish 	 NN	O
.  	.  	 .	O
Protein  	Protein  	 NN	O
content  	content  	 NN	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
Lowry  	Lowry  	 JJ	O
assay  	assay  	 NNS	O
( 	( 	 -LRB-	O
Sigma 	Sigma 	 NNP	O
.  	.  	 .	O
Diagnostics 	Diagnostics 	 NNP	O
,  	,  	 ,	O
St.  	St.  	 NNP	O
Louis 	Louis 	 NNP	O
,  	,  	 ,	O
MO 	MO 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Membranes  	Membranes  	 NNP	O
were  	were  	 VBD	O
initially  	initially  	 RB	O
prepared  	prepared  	 VBN	O
and  	and  	 CC	O
B  	B  	 NNP	O
max  	max  	 NN	O
and  	and  	 CC	O
K  	K  	 NNP	O
d  	d  	 SYM	O
values  	values  	 VBZ	O
determined  	determined  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
and  	and  	 CC	O
absence  	absence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
cocktail  	cocktail  	 NN	O
of  	of  	 IN	O
protease  	protease  	 JJ	O
inhibitors  	inhibitors  	 NNS	O
( 	( 	 -LRB-	O
Complete  	Complete  	 NNP	O
Protease  	Protease  	 NNP	O
Inhibitor  	Inhibitor  	 NNP	O
Cocktail 	Cocktail 	 NNP	O
,  	,  	 ,	O
Roche  	Roche  	 NNP	O
Diagnostics 	Diagnostics 	 NNPS	O
,  	,  	 ,	O
Mannheim  	Mannheim  	 NNP	O
Germany 	Germany 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
B  	B  	 NNP	O
max  	max  	 NN	O
was  	was  	 VBD	O
observed  	observed  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
omitting  	omitting  	 VBG	O
the  	the  	 DT	O
protease  	protease  	 JJ	O
inhibitor  	inhibitor  	 NNS	O
( 	( 	 -LRB-	O
B  	B  	 NNP	O
max  	max  	 NNS	O
( 	( 	 -LRB-	O
+  	+  	 FW	O
protease  	protease  	 FW	O
inhibitor 	inhibitor 	 FW	O
) 	) 	 -RRB-	O
=  	=  	 SYM	O
3.1  	3.1  	 FW	O
±  	±  	 FW	O
0.11  	0.11  	 FW	O
pmoles 	pmoles 	 FW	O
/ 	/ 	 FW	O
mg  	mg  	 FW	O
protein  	protein  	 FW	O
vs  	vs  	 FW	O
B  	B  	 NNP	O
max  	max  	 NNS	O
( 	( 	 -LRB-	O
-  	-  	 FW	O
protease  	protease  	 FW	O
inhibitor 	inhibitor 	 FW	O
)  	)  	 -RRB-	O
=  	=  	 SYM	O
3.2  	3.2  	 CD	O
±  	±  	 CD	O
0.13  	0.13  	 CD	O
pmoles 	pmoles 	 CD	O
/ 	/ 	 CD	O
mg  	mg  	 CD	O
protein. 	protein. 	 CD	O
)  	)  	 -RRB-	O
hence  	hence  	 RB	O
all  	all  	 DT	O
assays  	assays  	 NN	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cocktail 	cocktail 	 NN	O
.  	.  	 .	O
Binding  	Binding  	 JJ	O
assays  	assays  	 NN	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
in  	in  	 IN	O
PBS 	PBS 	 NNP	O
.  	.  	 .	O
For  	For  	 IN	O
K  	K  	 NNP	O
d  	d  	 SYM	O
determinations 	determinations 	 FW	O
,  	,  	 ,	O
100  	100  	 CD	O
μl  	μl  	 NN	O
of  	of  	 IN	O
homogenate  	homogenate  	 NN	O
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
1  	1  	 CD	O
hour  	hour  	 NN	O
with  	with  	 IN	O
varying  	varying  	 VBG	O
concentrations  	concentrations  	 NNS	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NNS	O
( 	( 	 -LRB-	O
NEN 	NEN 	 NNP	O
,  	,  	 ,	O
MA 	MA 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Specific  	Specific  	 JJ	O
binding  	binding  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NN	O
was  	was  	 VBD	O
determined  	determined  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
bound  	bound  	 NN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
not  	not  	 RB	O
displaced  	displaced  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
saturating  	saturating  	 JJ	O
concentration  	concentration  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
competing  	competing  	 JJ	O
ligand 	ligand 	 NN	O
.  	.  	 .	O
K  	K  	 NNP	O
d  	d  	 NN	O
values  	values  	 NNS	O
were  	were  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
fitting  	fitting  	 VBG	O
the  	the  	 DT	O
binding  	binding  	 JJ	O
data  	data  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
following  	following  	 JJ	O
equation  	equation  	 NN	O
using  	using  	 VBG	O
Graphpad  	Graphpad  	 NNP	O
PRISM  	PRISM  	 NNP	O
( 	( 	 -LRB-	O
San  	San  	 NNP	O
Diego  	Diego  	 NNP	O
CA 	CA 	 NNP	O
) 	) 	 -RRB-	O
:  	:  	 :	O
B  	B  	 NNP	O
=  	=  	 NNP	O
B  	B  	 NNP	O
max  	max  	 NNS	O
[ 	[ 	 -LRB-	O
L 	L 	 NNP	O
]  	]  	 -RRB-	O
n 	n 	 FW	O
/  	/  	 FW	O
( 	( 	 -LRB-	O
[ 	[ 	 -LRB-	O
L 	L 	 NNP	O
]  	]  	 -RRB-	O
n+  	n+  	 NNP	O
K  	K  	 NNP	O
n 	n 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
B  	B  	 NNP	O
is  	is  	 VBZ	O
bound  	bound  	 VBN	O
ligand 	ligand 	 NN	O
,  	,  	 ,	O
B  	B  	 NNP	O
max  	max  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
maximum  	maximum  	 JJ	O
binding  	binding  	 NN	O
at  	at  	 IN	O
equilibrium  	equilibrium  	 JJ	O
L  	L  	 NNP	O
is  	is  	 VBZ	O
the  	the  	 DT	O
free  	free  	 JJ	O
ligand  	ligand  	 JJ	O
concentration  	concentration  	 NN	O
and  	and  	 CC	O
n  	n  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
Hill  	Hill  	 NNP	O
coefficient 	coefficient 	 NN	O
.  	.  	 .	O
K  	K  	 NNP	O
i  	i  	 FW	O
determinations 	determinations 	 FW	O
,  	,  	 ,	O
100  	100  	 CD	O
μl  	μl  	 NN	O
of  	of  	 IN	O
homogenate  	homogenate  	 NN	O
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
2  	2  	 CD	O
hours  	hours  	 NNS	O
with  	with  	 IN	O
varying  	varying  	 VBG	O
concentrations  	concentrations  	 NNS	O
of  	of  	 IN	O
inhibitor  	inhibitor  	 NN	O
and  	and  	 CC	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 NNS	O
( 	( 	 -LRB-	O
NEN 	NEN 	 NNP	O
,  	,  	 ,	O
MA 	MA 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Binding  	Binding  	 NNP	O
was  	was  	 VBD	O
terminated  	terminated  	 VBN	O
by  	by  	 IN	O
rapid  	rapid  	 JJ	O
filtration  	filtration  	 NN	O
onto  	onto  	 IN	O
a  	a  	 DT	O
GF 	GF 	 NNP	O
/ 	/ 	 NNP	O
B  	B  	 NNP	O
filters 	filters 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
values  	values  	 NNS	O
were  	were  	 VBD	O
calculated  	calculated  	 VBN	O
by  	by  	 IN	O
fitting  	fitting  	 VBG	O
the  	the  	 DT	O
data  	data  	 NNS	O
to  	to  	 TO	O
the  	the  	 DT	O
following  	following  	 JJ	O
equation  	equation  	 NN	O
using  	using  	 VBG	O
Graphpad  	Graphpad  	 NNP	O
PRISM  	PRISM  	 NNP	O
( 	( 	 -LRB-	O
San  	San  	 NNP	O
Diego  	Diego  	 NNP	O
CA 	CA 	 NNP	O
) 	) 	 -RRB-	O
:  	:  	 :	O
θ  	θ  	 CD	O
=  	=  	 SYM	O
1 	1 	 CD	O
/  	/  	 CD	O
( 	( 	 -LRB-	O
1+ 	1+ 	 NNP	O
( 	( 	 -LRB-	O
L 	L 	 NNP	O
/ 	/ 	 NNP	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
θ  	θ  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
fractional  	fractional  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
bound  	bound  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
inhibitor  	inhibitor  	 NN	O
at  	at  	 IN	O
concentration  	concentration  	 NN	O
L  	L  	 NNP	O
as  	as  	 RB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
[  	[  	 -LRB-	O
3H 	3H 	 NNP	O
] 	] 	 -RRB-	O
granisetron  	granisetron  	 VBZ	O
bound  	bound  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	O
of  	of  	 IN	O
inhibitor 	inhibitor 	 NN	O
.  	.  	 .	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
is  	is  	 VBZ	O
the  	the  	 DT	O
concentration  	concentration  	 NN	O
at  	at  	 IN	O
which  	which  	 WDT	O
θ  	θ  	 VBD	O
=  	=  	 CD	O
0.5 	0.5 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
K  	K  	 NNP	O
i  	i  	 FW	O
is  	is  	 VBZ	O
calculated  	calculated  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
IC  	IC  	 NNP	O
50  	50  	 CD	O
value  	value  	 NN	O
using  	using  	 VBG	O
the  	the  	 DT	O
Cheng-Prusoff  	Cheng-Prusoff  	 JJ	O
equation 	equation 	 NN	O
.  	.  	 .	O
Electrophysiological  	Electrophysiological  	 NNP	O
Recordings  	Recordings  	 NNP	O
Transfected  	Transfected  	 NNP	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
transferred  	transferred  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
recording  	recording  	 NN	O
chamber  	chamber  	 NN	O
containing  	containing  	 VBG	O
extracellular  	extracellular  	 JJ	O
solution  	solution  	 NN	O
( 	( 	 -LRB-	O
140  	140  	 CD	O
mM  	mM  	 JJ	O
NaCl 	NaCl 	 NN	O
,  	,  	 ,	O
1.7  	1.7  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	O
2  	2  	 CD	O
,  	,  	 ,	O
5  	5  	 CD	O
mM  	mM  	 JJ	O
KCl 	KCl 	 NN	O
,  	,  	 ,	O
1.8  	1.8  	 CD	O
mM  	mM  	 JJ	O
CaCl  	CaCl  	 JJ	O
2  	2  	 CD	O
,  	,  	 ,	O
25  	25  	 CD	O
mM  	mM  	 JJ	O
HEPES  	HEPES  	 NNP	O
pH  	pH  	 NNP	O
7.4 	7.4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Patch  	Patch  	 JJ	O
electrodes  	electrodes  	 NNS	O
of  	of  	 IN	O
resistance  	resistance  	 NN	O
2.5-3.0  	2.5-3.0  	 NNP	O
MΩ  	MΩ  	 NNP	O
were  	were  	 VBD	O
filled  	filled  	 VBN	O
with  	with  	 IN	O
filtered  	filtered  	 JJ	O
intracellular  	intracellular  	 JJ	O
solution  	solution  	 NN	O
containing  	containing  	 VBG	O
145  	145  	 CD	O
mM  	mM  	 JJ	O
KCl 	KCl 	 NN	O
,  	,  	 ,	O
2  	2  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	O
2  	2  	 CD	O
,  	,  	 ,	O
1  	1  	 CD	O
mM  	mM  	 JJ	O
EGTA 	EGTA 	 NNP	O
,  	,  	 ,	O
25  	25  	 CD	O
mM  	mM  	 JJ	O
HEPES  	HEPES  	 NNP	O
( 	( 	 -LRB-	O
pH  	pH  	 NNP	O
7.4 	7.4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
clamped  	clamped  	 VBN	O
in  	in  	 IN	O
whole  	whole  	 JJ	O
cell  	cell  	 NN	O
configuration  	configuration  	 NN	O
at  	at  	 IN	O
a  	a  	 DT	O
holding  	holding  	 NN	B-NP
potential  	potential  	 NN	I-NP
of  	of  	 IN	O
-60  	-60  	 NNP	O
mV 	mV 	 NNP	O
.  	.  	 .	O
A  	A  	 DT	O
continuous  	continuous  	 JJ	B-NP
extracellular  	extracellular  	 JJ	I-NP
solution  	solution  	 NN	I-NP
flow  	flow  	 NN	I-NP
( 	( 	 -LRB-	O
0.8  	0.8  	 FW	O
ml 	ml 	 FW	B-NP
/ 	/ 	 FW	I-NP
min 	min 	 FW	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
maintained  	maintained  	 VBN	O
throughout  	throughout  	 IN	O
the  	the  	 DT	O
recording  	recording  	 NN	B-NP
procedure.  	procedure.  	 NNP	I-NP
5-HT  	5-HT  	 NNP	O
was  	was  	 VBD	O
dissolved  	dissolved  	 VBN	O
in  	in  	 IN	O
extracellular  	extracellular  	 JJ	B-NP
solution  	solution  	 NN	I-NP
and  	and  	 CC	O
delivered  	delivered  	 VBN	O
to  	to  	 TO	O
cells  	cells  	 NNS	O
using  	using  	 VBG	O
a  	a  	 DT	O
rapid  	rapid  	 JJ	B-NP
perfusion  	perfusion  	 JJ	I-NP
system  	system  	 NN	I-NP
( 	( 	 -LRB-	O
Warner  	Warner  	 NNP	O
Instruments 	Instruments 	 NNP	O
,  	,  	 ,	O
Hamden 	Hamden 	 NNP	O
,  	,  	 ,	O
CT 	CT 	 NNP	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
a  	a  	 DT	O
rate  	rate  	 NN	O
matching  	matching  	 VBG	O
the  	the  	 DT	O
extracellular  	extracellular  	 JJ	B-NP
solution  	solution  	 NN	I-NP
flow  	flow  	 NN	I-NP
rate 	rate 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
drug  	drug  	 NN	O
perfusions  	perfusions  	 VBZ	O
lasted  	lasted  	 VBN	O
for  	for  	 IN	O
a  	a  	 DT	O
period  	period  	 NN	O
varying  	varying  	 VBG	O
from  	from  	 IN	O
4  	4  	 CD	O
to  	to  	 TO	O
8  	8  	 CD	O
seconds 	seconds 	 NNS	O
.  	.  	 .	O
Currents  	Currents  	 JJ	O
elicited  	elicited  	 NN	O
by  	by  	 IN	O
agonist  	agonist  	 JJ	B-NP
application  	application  	 NN	I-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
an  	an  	 DT	O
Axopatch  	Axopatch  	 NNP	B-NP
200  	200  	 CD	O
B  	B  	 NN	B-NP
amplifier  	amplifier  	 NNS	I-NP
( 	( 	 -LRB-	O
Foster  	Foster  	 NNP	O
City 	City 	 NNP	O
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
data  	data  	 NNS	O
were  	were  	 VBD	O
plotted  	plotted  	 JJ	O
and  	and  	 CC	O
analyzed  	analyzed  	 VBD	O
by  	by  	 IN	O
non-linear  	non-linear  	 JJ	B-NP
curve  	curve  	 NN	I-NP
fitting  	fitting  	 NNS	I-NP
( 	( 	 -LRB-	O
Graphpad  	Graphpad  	 NNP	B-NP
PRISM 	PRISM 	 NNP	I-NP
,  	,  	 ,	O
San  	San  	 NNP	B-NP
Diego  	Diego  	 NNP	I-NP
CA 	CA 	 NNP	I-NP
)  	)  	 -RRB-	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
following  	following  	 JJ	O
equation 	equation 	 NN	O
:  	:  	 :	O
I  	I  	 PRP	O
=  	=  	 SYM	O
1 	1 	 CD	O
/ 	/ 	 CD	O
( 	( 	 -LRB-	O
1  	1  	 CD	O
+ 	+ 	 CD	O
( 	( 	 -LRB-	O
EC  	EC  	 NNP	O
50  	50  	 CD	O
/  	/  	 CD	O
[ 	[ 	 -LRB-	O
C 	C 	 $	O
] 	] 	 CD	O
)  	)  	 -RRB-	O
n 	n 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
where  	where  	 WRB	O
is  	is  	 VBZ	O
the  	the  	 DT	O
normalized  	normalized  	 JJ	O
current  	current  	 JJ	O
at  	at  	 IN	O
5-HT  	5-HT  	 CD	O
concentration  	concentration  	 NN	O
[ 	[ 	 -LRB-	O
C 	C 	 NNP	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
EC  	EC  	 NNP	B-NP
50  	50  	 CD	O
is  	is  	 VBZ	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
of  	of  	 IN	O
5-HT  	5-HT  	 NNP	O
needed  	needed  	 VBD	O
to  	to  	 TO	O
obtain  	obtain  	 VB	O
half  	half  	 DT	O
maximal  	maximal  	 JJ	B-NP
activation  	activation  	 NN	I-NP
and  	and  	 CC	O
n  	n  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
apparent  	apparent  	 JJ	O
Hill  	Hill  	 NNP	O
coefficient 	coefficient 	 NN	O
.  	.  	 .	O
